pharmaobservatory 0.1.2 → 0.1.3
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +130 -418
- data/docs/BiomarkerBqpAssertionsResponse.md +58 -0
- data/docs/BiomarkerBqpAssertionsRow.md +62 -0
- data/docs/BiomarkerCdxAssertionsResponse.md +58 -0
- data/docs/BiomarkerCdxAssertionsResponseBuild.md +20 -0
- data/docs/BiomarkerCdxAssertionsResponseFreshness.md +20 -0
- data/docs/BiomarkerCdxAssertionsResponseScope.md +22 -0
- data/docs/BiomarkerCdxAssertionsRow.md +50 -0
- data/docs/BiomarkerEvidenceResponse.md +58 -0
- data/docs/BiomarkerEvidenceRow.md +54 -0
- data/docs/BiomarkerLiteratureResponse.md +58 -0
- data/docs/BiomarkerLiteratureRow.md +38 -0
- data/docs/BiomarkerPublishingCompaniesResponse.md +58 -0
- data/docs/BiomarkerPublishingCompaniesRow.md +44 -0
- data/docs/BiomarkerVariantMentionsResponse.md +58 -0
- data/docs/BiomarkerVariantMentionsRow.md +44 -0
- data/docs/BiomarkersApi.md +189 -1152
- data/docs/BiomarkersRecord.md +38 -0
- data/docs/BiomarkersResponse.md +58 -0
- data/docs/BiomarkersRow.md +68 -0
- data/docs/CellLinesApi.md +26 -230
- data/docs/CellLinesRecord.md +38 -0
- data/docs/CellLinesResponse.md +58 -0
- data/docs/CellLinesRow.md +54 -0
- data/docs/CompaniesApi.md +1301 -0
- data/docs/CompaniesRecord.md +38 -0
- data/docs/CompaniesResponse.md +58 -0
- data/docs/CompaniesRow.md +64 -0
- data/docs/CompanyMembersResponse.md +58 -0
- data/docs/CompanyMembersRow.md +42 -0
- data/docs/CompanyProgramsResponse.md +58 -0
- data/docs/CompanyProgramsRow.md +50 -0
- data/docs/CompanyTargetsResponse.md +58 -0
- data/docs/CompanyTargetsRow.md +38 -0
- data/docs/DatasetAttribution.md +26 -0
- data/docs/DatasetBuildState.md +22 -0
- data/docs/DatasetColumn.md +30 -0
- data/docs/DatasetListing.md +32 -0
- data/docs/DatasetSummaryList.md +18 -0
- data/docs/DatasetSummaryListDatasetsInner.md +32 -0
- data/docs/DatasetsApi.md +140 -0
- data/docs/DrugPatentCliffResponse.md +58 -0
- data/docs/DrugPatentCliffRow.md +68 -0
- data/docs/InstitutionalHoldingsResponse.md +58 -0
- data/docs/InstitutionalHoldingsRow.md +64 -0
- data/docs/LegalEntitiesApi.md +793 -0
- data/docs/LegalEntitiesRecord.md +38 -0
- data/docs/LegalEntitiesRecordAttributes.md +18 -0
- data/docs/LegalEntitiesResponse.md +58 -0
- data/docs/LegalEntitiesRow.md +56 -0
- data/docs/PdufaDatesResponse.md +58 -0
- data/docs/PdufaDatesRow.md +66 -0
- data/docs/QueryApi.md +149 -0
- data/docs/QueryError.md +24 -0
- data/docs/QueryResponse.md +42 -0
- data/docs/QueryResponseColumnsInner.md +20 -0
- data/docs/QueryRunRequest.md +18 -0
- data/docs/ResultPage.md +38 -0
- data/docs/SiteBedsYearlyResponse.md +58 -0
- data/docs/SiteBedsYearlyRow.md +30 -0
- data/docs/SiteCroTrialsResponse.md +58 -0
- data/docs/SiteCroTrialsRow.md +40 -0
- data/docs/SiteHospitalsResponse.md +58 -0
- data/docs/SiteHospitalsRow.md +42 -0
- data/docs/SiteInvestigatorsResponse.md +58 -0
- data/docs/SiteInvestigatorsRow.md +30 -0
- data/docs/SiteTrialConditionsResponse.md +58 -0
- data/docs/SiteTrialConditionsRow.md +28 -0
- data/docs/SiteTrialDrugsResponse.md +58 -0
- data/docs/SiteTrialDrugsRow.md +28 -0
- data/docs/SiteTrialsResponse.md +58 -0
- data/docs/SiteTrialsRow.md +46 -0
- data/docs/SitesApi.md +713 -0
- data/docs/SitesRecord.md +38 -0
- data/docs/SitesRecordAttributes.md +18 -0
- data/docs/SitesResponse.md +58 -0
- data/docs/SitesRow.md +54 -0
- data/docs/SponsorRecruitmentByPhaseResponse.md +58 -0
- data/docs/SponsorRecruitmentByPhaseRow.md +58 -0
- data/docs/SponsorRecruitmentDurationResponse.md +58 -0
- data/docs/SponsorRecruitmentDurationRow.md +94 -0
- data/docs/SponsorTrialStartForecastResponse.md +58 -0
- data/docs/SponsorTrialStartForecastRow.md +70 -0
- data/docs/SponsorTrialsResponse.md +58 -0
- data/docs/SponsorTrialsRow.md +58 -0
- data/lib/pharmaobservatory/api/biomarkers_api.rb +246 -1030
- data/lib/pharmaobservatory/api/cell_lines_api.rb +33 -202
- data/lib/pharmaobservatory/api/companies_api.rb +1435 -0
- data/lib/pharmaobservatory/api/datasets_api.rb +138 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +833 -0
- data/lib/pharmaobservatory/api/query_api.rb +148 -0
- data/lib/pharmaobservatory/api/sites_api.rb +749 -0
- data/lib/pharmaobservatory/models/{orgs_activity_summary200_response.rb → biomarker_bqp_assertions_response.rb} +170 -195
- data/lib/pharmaobservatory/models/{biomarkers_fda_bqp200_response_rows_inner.rb → biomarker_bqp_assertions_row.rb} +182 -186
- data/lib/pharmaobservatory/models/{biomarkers_evidence_over_time200_response.rb → biomarker_cdx_assertions_response.rb} +167 -187
- data/lib/pharmaobservatory/models/{orgs_org_customer200_response_rows_inner.rb → biomarker_cdx_assertions_response_build.rb} +21 -27
- data/lib/pharmaobservatory/models/{biomarkers_list200_response_query_filters.rb → biomarker_cdx_assertions_response_freshness.rb} +18 -20
- data/lib/pharmaobservatory/models/{biomarkers_where_it_appears200_response_rows_inner.rb → biomarker_cdx_assertions_response_scope.rb} +47 -48
- data/lib/pharmaobservatory/models/{biomarkers_fda_cdx200_response_rows_inner.rb → biomarker_cdx_assertions_row.rb} +134 -204
- data/lib/pharmaobservatory/models/biomarker_evidence_response.rb +478 -0
- data/lib/pharmaobservatory/models/{biomarkers_cgi200_response_rows_inner.rb → biomarker_evidence_row.rb} +167 -177
- data/lib/pharmaobservatory/models/{orgs_declarations200_response.rb → biomarker_literature_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{biomarkers_literature200_response_rows_inner.rb → biomarker_literature_row.rb} +75 -109
- data/lib/pharmaobservatory/models/{cell_lines_safety_resolution200_response.rb → biomarker_publishing_companies_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{biomarkers_publishing_org200_response_rows_inner.rb → biomarker_publishing_companies_row.rb} +111 -162
- data/lib/pharmaobservatory/models/{orgs_related_conditions200_response.rb → biomarker_variant_mentions_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{biomarkers_variant_mentions200_response_rows_inner.rb → biomarker_variant_mentions_row.rb} +116 -115
- data/lib/pharmaobservatory/models/{not_entitled_error.rb → biomarkers_record.rb} +109 -113
- data/lib/pharmaobservatory/models/{biomarkers_population_allele_frequency200_response.rb → biomarkers_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{biomarkers_list200_response_rows_inner.rb → biomarkers_row.rb} +141 -276
- data/lib/pharmaobservatory/models/{orgs_get200_response.rb → cell_lines_record.rb} +94 -132
- data/lib/pharmaobservatory/models/{biomarkers_related_biomarkers200_response.rb → cell_lines_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{cell_lines_list200_response_rows_inner.rb → cell_lines_row.rb} +129 -147
- data/lib/pharmaobservatory/models/{cell_lines_get200_response.rb → companies_record.rb} +94 -132
- data/lib/pharmaobservatory/models/{biomarkers_coverage_by_traversal200_response.rb → companies_response.rb} +172 -183
- data/lib/pharmaobservatory/models/companies_row.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_company200_response.rb → company_members_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{orgs_member_identity200_response_context.rb → company_members_row.rb} +118 -136
- data/lib/pharmaobservatory/models/{orgs_coverage200_response.rb → company_programs_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{orgs_org_assets200_response_rows_inner.rb → company_programs_row.rb} +146 -166
- data/lib/pharmaobservatory/models/company_targets_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_org_targets200_response_rows_inner.rb → company_targets_row.rb} +100 -134
- data/lib/pharmaobservatory/models/{orgs_esg_trend200_response_attribution_inner.rb → dataset_attribution.rb} +26 -41
- data/lib/pharmaobservatory/models/{biomarkers_relations200_response_query.rb → dataset_build_state.rb} +30 -27
- data/lib/pharmaobservatory/models/{biomarkers_list200_response_attribution_inner.rb → dataset_column.rb} +57 -53
- data/lib/pharmaobservatory/models/{biomarkers_assay_provider_ledger200_response_attribution_inner.rb → dataset_listing.rb} +57 -47
- data/lib/pharmaobservatory/models/{cell_lines_list200_response_query_filters.rb → dataset_summary_list.rb} +11 -11
- data/lib/pharmaobservatory/models/{biomarkers_cgi200_response_attribution_inner.rb → dataset_summary_list_datasets_inner.rb} +64 -67
- data/lib/pharmaobservatory/models/{orgs_org_gleif200_response.rb → drug_patent_cliff_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{orgs_patent_cliff200_response_rows_inner.rb → drug_patent_cliff_row.rb} +210 -141
- data/lib/pharmaobservatory/models/{orgs_import_refusals200_response.rb → institutional_holdings_response.rb} +172 -183
- data/lib/pharmaobservatory/models/institutional_holdings_row.rb +476 -0
- data/lib/pharmaobservatory/models/legal_entities_record.rb +385 -0
- data/lib/pharmaobservatory/models/{cell_lines_list200_response_query.rb → legal_entities_record_attributes.rb} +10 -27
- data/lib/pharmaobservatory/models/legal_entities_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_group_structure200_response_rows_inner.rb → legal_entities_row.rb} +178 -175
- data/lib/pharmaobservatory/models/pdufa_dates_response.rb +478 -0
- data/lib/pharmaobservatory/models/pdufa_dates_row.rb +487 -0
- data/lib/pharmaobservatory/models/{biomarkers_relations400_response.rb → query_error.rb} +35 -44
- data/lib/pharmaobservatory/models/{cell_lines_get200_response_identity.rb → query_response.rb} +149 -8
- data/lib/pharmaobservatory/models/{orgs_esg_trend200_response_context.rb → query_response_columns_inner.rb} +19 -27
- data/lib/pharmaobservatory/models/{biomarkers_list200_response_shape.rb → query_run_request.rb} +19 -19
- data/lib/pharmaobservatory/models/{orgs_get200_response_identity.rb → result_page.rb} +113 -8
- data/lib/pharmaobservatory/models/site_beds_yearly_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_member_identity200_response_context_parent.rb → site_beds_yearly_row.rb} +73 -73
- data/lib/pharmaobservatory/models/site_cro_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_ownership_percentages200_response_context.rb → site_cro_trials_row.rb} +122 -93
- data/lib/pharmaobservatory/models/site_hospitals_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_timeline200_response_rows_inner.rb → site_hospitals_row.rb} +121 -112
- data/lib/pharmaobservatory/models/site_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_approved_assets200_response_rows_inner.rb → site_investigators_row.rb} +64 -90
- data/lib/pharmaobservatory/models/{orgs_org_type_tally200_response.rb → site_trial_conditions_response.rb} +171 -194
- data/lib/pharmaobservatory/models/{biomarkers_sample_screening200_response_context_coverage_counts.rb → site_trial_conditions_row.rb} +65 -50
- data/lib/pharmaobservatory/models/site_trial_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_top_drugs200_response_rows_inner.rb → site_trial_drugs_row.rb} +65 -50
- data/lib/pharmaobservatory/models/site_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/{orgs_org_pipeline200_response_rows_inner.rb → site_trials_row.rb} +139 -129
- data/lib/pharmaobservatory/models/{orgs_member_records200_response_rows_inner.rb → sites_record.rb} +139 -43
- data/lib/pharmaobservatory/models/sites_record_attributes.rb +220 -0
- data/lib/pharmaobservatory/models/{biomarkers_related_conditions200_response.rb → sites_response.rb} +172 -183
- data/lib/pharmaobservatory/models/{orgs_gxp_sites200_response_rows_inner.rb → sites_row.rb} +145 -198
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_recruitment_by_phase_row.rb +443 -0
- data/lib/pharmaobservatory/models/{biomarkers_hub_tier_tables200_response.rb → sponsor_recruitment_duration_response.rb} +174 -171
- data/lib/pharmaobservatory/models/sponsor_recruitment_duration_row.rb +641 -0
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_start_forecast_row.rb +509 -0
- data/lib/pharmaobservatory/models/sponsor_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trials_row.rb +447 -0
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +82 -299
- metadata +166 -600
- data/docs/BiomarkersAssayProviderLedger200Response.md +0 -40
- data/docs/BiomarkersAssayProviderLedger200ResponseAttributionInner.md +0 -22
- data/docs/BiomarkersAssayProviderLedger200ResponsePagination.md +0 -28
- data/docs/BiomarkersAssayProviderLedger200ResponseRowsInner.md +0 -42
- data/docs/BiomarkersCgi200Response.md +0 -40
- data/docs/BiomarkersCgi200ResponseAttributionInner.md +0 -22
- data/docs/BiomarkersCgi200ResponseRowsInner.md +0 -34
- data/docs/BiomarkersCoverageByTraversal200Response.md +0 -38
- data/docs/BiomarkersCoverageByTraversal200ResponseRowsInner.md +0 -28
- data/docs/BiomarkersEvidenceOverTime200Response.md +0 -40
- data/docs/BiomarkersEvidenceOverTime200ResponseContext.md +0 -18
- data/docs/BiomarkersEvidenceOverTime200ResponseRowsInner.md +0 -32
- data/docs/BiomarkersFdaBqp200Response.md +0 -40
- data/docs/BiomarkersFdaBqp200ResponseRowsInner.md +0 -38
- data/docs/BiomarkersFdaCdx200Response.md +0 -40
- data/docs/BiomarkersFdaCdx200ResponseRowsInner.md +0 -38
- data/docs/BiomarkersGet200Response.md +0 -32
- data/docs/BiomarkersGet200ResponseIdentity.md +0 -20
- data/docs/BiomarkersGet200ResponseIdentityRowsInner.md +0 -22
- data/docs/BiomarkersGet200ResponseIdentityRowsInnerValue.md +0 -49
- data/docs/BiomarkersGet200ResponseResolutionConfidence.md +0 -20
- data/docs/BiomarkersGet200ResponseSectionsInner.md +0 -34
- data/docs/BiomarkersHubTierTables200Response.md +0 -38
- data/docs/BiomarkersHubTierTables200ResponseRowsInner.md +0 -28
- data/docs/BiomarkersIdentity200Response.md +0 -40
- data/docs/BiomarkersList200Response.md +0 -44
- data/docs/BiomarkersList200ResponseAttributionInner.md +0 -22
- data/docs/BiomarkersList200ResponseBuildState.md +0 -22
- data/docs/BiomarkersList200ResponseColumnsInner.md +0 -22
- data/docs/BiomarkersList200ResponseFacetsInner.md +0 -22
- data/docs/BiomarkersList200ResponseFacetsInnerOptionsInner.md +0 -22
- data/docs/BiomarkersList200ResponsePagination.md +0 -28
- data/docs/BiomarkersList200ResponseQuery.md +0 -28
- data/docs/BiomarkersList200ResponseQueryFilters.md +0 -20
- data/docs/BiomarkersList200ResponseRowsInner.md +0 -56
- data/docs/BiomarkersList200ResponseShape.md +0 -18
- data/docs/BiomarkersLiterature200Response.md +0 -42
- data/docs/BiomarkersLiterature200ResponseContext.md +0 -20
- data/docs/BiomarkersLiterature200ResponseRowsInner.md +0 -28
- data/docs/BiomarkersOtAssociation200Response.md +0 -40
- data/docs/BiomarkersOtAssociation200ResponseRowsInner.md +0 -28
- data/docs/BiomarkersPopulationAlleleFrequency200Response.md +0 -38
- data/docs/BiomarkersPopulationAlleleFrequency200ResponseAttributionInner.md +0 -24
- data/docs/BiomarkersPopulationAlleleFrequency200ResponseRowsInner.md +0 -38
- data/docs/BiomarkersPublishingOrg200Response.md +0 -42
- data/docs/BiomarkersPublishingOrg200ResponseContext.md +0 -24
- data/docs/BiomarkersPublishingOrg200ResponseRowsInner.md +0 -34
- data/docs/BiomarkersRelatedBiomarkers200Response.md +0 -38
- data/docs/BiomarkersRelatedBiomarkers200ResponseRowsInner.md +0 -22
- data/docs/BiomarkersRelatedConditions200Response.md +0 -38
- data/docs/BiomarkersRelatedOrganizations200Response.md +0 -38
- data/docs/BiomarkersRelations200Response.md +0 -44
- data/docs/BiomarkersRelations200ResponseContext.md +0 -20
- data/docs/BiomarkersRelations200ResponseContextFilters.md +0 -24
- data/docs/BiomarkersRelations200ResponseQuery.md +0 -18
- data/docs/BiomarkersRelations200ResponseRowsInner.md +0 -32
- data/docs/BiomarkersRelations400Response.md +0 -22
- data/docs/BiomarkersSampleScreening200Response.md +0 -42
- data/docs/BiomarkersSampleScreening200ResponseContext.md +0 -26
- data/docs/BiomarkersSampleScreening200ResponseContextCoverageCounts.md +0 -20
- data/docs/BiomarkersSampleScreening200ResponseRowsInner.md +0 -38
- data/docs/BiomarkersSampleScreening200ResponseRowsInnerReferenceScreens.md +0 -22
- data/docs/BiomarkersTrialMention200Response.md +0 -40
- data/docs/BiomarkersTrialMention200ResponseRowsInner.md +0 -26
- data/docs/BiomarkersVariantMentions200Response.md +0 -40
- data/docs/BiomarkersVariantMentions200ResponseRowsInner.md +0 -28
- data/docs/BiomarkersVendorSourcing200Response.md +0 -42
- data/docs/BiomarkersVendorSourcing200ResponseQuery.md +0 -18
- data/docs/BiomarkersVendorSourcing200ResponseRowsInner.md +0 -46
- data/docs/BiomarkersWhereItAppears200Response.md +0 -38
- data/docs/BiomarkersWhereItAppears200ResponseRowsInner.md +0 -22
- data/docs/CellLinesGet200Response.md +0 -32
- data/docs/CellLinesGet200ResponseIdentity.md +0 -20
- data/docs/CellLinesGet200ResponseIdentityRowsInner.md +0 -22
- data/docs/CellLinesIdentity200Response.md +0 -40
- data/docs/CellLinesList200Response.md +0 -44
- data/docs/CellLinesList200ResponseAttributionInner.md +0 -26
- data/docs/CellLinesList200ResponseQuery.md +0 -18
- data/docs/CellLinesList200ResponseQueryFilters.md +0 -18
- data/docs/CellLinesList200ResponseRowsInner.md +0 -38
- data/docs/CellLinesSafetyResolution200Response.md +0 -38
- data/docs/CellLinesSafetyResolution200ResponseRowsInner.md +0 -22
- data/docs/CellLinesSafetyResolution200ResponseRowsInnerValue.md +0 -49
- data/docs/CellLinesStatusCounts200Response.md +0 -38
- data/docs/CellLinesStatusCounts200ResponseRowsInner.md +0 -22
- data/docs/NotEntitledError.md +0 -44
- data/docs/OrgsActivePrograms200Response.md +0 -40
- data/docs/OrgsActivitySummary200Response.md +0 -38
- data/docs/OrgsActivitySummary200ResponseRowsInner.md +0 -20
- data/docs/OrgsApi.md +0 -5982
- data/docs/OrgsApprovedAssets200Response.md +0 -42
- data/docs/OrgsApprovedAssets200ResponseContext.md +0 -20
- data/docs/OrgsApprovedAssets200ResponseRowsInner.md +0 -24
- data/docs/OrgsBenzingaCatalysts200Response.md +0 -40
- data/docs/OrgsBenzingaCatalysts200ResponseAttributionInner.md +0 -22
- data/docs/OrgsBenzingaCatalysts200ResponseRestriction.md +0 -22
- data/docs/OrgsBiomarkerCapability200Response.md +0 -40
- data/docs/OrgsClia200Response.md +0 -40
- data/docs/OrgsClimate200Response.md +0 -40
- data/docs/OrgsClimate200ResponseRowsInner.md +0 -56
- data/docs/OrgsCollaborators200Response.md +0 -38
- data/docs/OrgsCollaborators200ResponseRowsInner.md +0 -24
- data/docs/OrgsCompany200Response.md +0 -38
- data/docs/OrgsCompany200ResponseRowsInner.md +0 -86
- data/docs/OrgsCompetitors200Response.md +0 -38
- data/docs/OrgsCompetitors200ResponseRowsInner.md +0 -58
- data/docs/OrgsCoverage200Response.md +0 -38
- data/docs/OrgsCoverage200ResponseRowsInner.md +0 -22
- data/docs/OrgsCoverage200ResponseRowsInnerValue.md +0 -49
- data/docs/OrgsCurrentOwnership200Response.md +0 -42
- data/docs/OrgsCurrentOwnership200ResponseAttributionInner.md +0 -24
- data/docs/OrgsCurrentOwnership200ResponseContext.md +0 -22
- data/docs/OrgsCurrentOwnership200ResponseContextTotals.md +0 -20
- data/docs/OrgsCurrentOwnership200ResponseRowsInner.md +0 -72
- data/docs/OrgsDeclarations200Response.md +0 -38
- data/docs/OrgsDeclarations200ResponseRowsInner.md +0 -40
- data/docs/OrgsDelivery200Response.md +0 -38
- data/docs/OrgsDelivery200ResponseRowsInner.md +0 -32
- data/docs/OrgsDescription200Response.md +0 -38
- data/docs/OrgsDescription200ResponseRowsInner.md +0 -20
- data/docs/OrgsDiseaseAreas200Response.md +0 -42
- data/docs/OrgsDiseaseAreas200ResponseRowsInner.md +0 -22
- data/docs/OrgsDiversity200Response.md +0 -40
- data/docs/OrgsDiversity200ResponseRowsInner.md +0 -50
- data/docs/OrgsEsgTrend200Response.md +0 -40
- data/docs/OrgsEsgTrend200ResponseAttributionInner.md +0 -22
- data/docs/OrgsEsgTrend200ResponseContext.md +0 -18
- data/docs/OrgsEsgTrend200ResponseRowsInner.md +0 -32
- data/docs/OrgsFinancialLineItems200Response.md +0 -40
- data/docs/OrgsFinancialLineItems200ResponseContext.md +0 -22
- data/docs/OrgsFinancialLineItems200ResponseContextGroupsInner.md +0 -22
- data/docs/OrgsFinancialLineItems200ResponseRowsInner.md +0 -28
- data/docs/OrgsFinancialOverview200Response.md +0 -40
- data/docs/OrgsFinancialOverview200ResponseContext.md +0 -20
- data/docs/OrgsFinancialOverview200ResponseRowsInner.md +0 -22
- data/docs/OrgsFinancialOverview200ResponseRowsInnerValue.md +0 -53
- data/docs/OrgsFinancials200Response.md +0 -42
- data/docs/OrgsFinancials200ResponseRowsInner.md +0 -26
- data/docs/OrgsFunding200Response.md +0 -42
- data/docs/OrgsFunding200ResponseContext.md +0 -32
- data/docs/OrgsFunding200ResponseContextSummary.md +0 -28
- data/docs/OrgsFunding200ResponseRowsInner.md +0 -38
- data/docs/OrgsGet200Response.md +0 -32
- data/docs/OrgsGet200ResponseIdentity.md +0 -20
- data/docs/OrgsGet200ResponseIdentityRowsInner.md +0 -22
- data/docs/OrgsGet200ResponseIdentityRowsInnerValue.md +0 -55
- data/docs/OrgsGet200ResponseSectionsInner.md +0 -34
- data/docs/OrgsGroupSections200Response.md +0 -40
- data/docs/OrgsGroupSections200ResponseContext.md +0 -28
- data/docs/OrgsGroupSections200ResponseRowsInner.md +0 -34
- data/docs/OrgsGroupStructure200Response.md +0 -40
- data/docs/OrgsGroupStructure200ResponseContext.md +0 -22
- data/docs/OrgsGroupStructure200ResponseRowsInner.md +0 -36
- data/docs/OrgsGxpSites200Response.md +0 -42
- data/docs/OrgsGxpSites200ResponseContext.md +0 -24
- data/docs/OrgsGxpSites200ResponseContextGroupCompaniesInner.md +0 -22
- data/docs/OrgsGxpSites200ResponseRowsInner.md +0 -50
- data/docs/OrgsGxpSitesMap200Response.md +0 -40
- data/docs/OrgsIdentity200Response.md +0 -40
- data/docs/OrgsImportRefusals200Response.md +0 -38
- data/docs/OrgsInstitutional13f200Response.md +0 -42
- data/docs/OrgsInstitutional13f200ResponseContext.md +0 -22
- data/docs/OrgsInstitutional13f200ResponseRowsInner.md +0 -62
- data/docs/OrgsJournals200Response.md +0 -42
- data/docs/OrgsList200Response.md +0 -42
- data/docs/OrgsList200ResponsePagination.md +0 -28
- data/docs/OrgsList200ResponseQuery.md +0 -26
- data/docs/OrgsList200ResponseRowsInner.md +0 -44
- data/docs/OrgsMemberChildren200Response.md +0 -38
- data/docs/OrgsMemberIdentity200Response.md +0 -42
- data/docs/OrgsMemberIdentity200ResponseContext.md +0 -28
- data/docs/OrgsMemberIdentity200ResponseContextIdentifiersInner.md +0 -22
- data/docs/OrgsMemberIdentity200ResponseContextParent.md +0 -22
- data/docs/OrgsMemberIdentity200ResponseRowsInner.md +0 -26
- data/docs/OrgsMemberRecords200Response.md +0 -40
- data/docs/OrgsMemberRecords200ResponseContext.md +0 -18
- data/docs/OrgsMemberRecords200ResponseRowsInner.md +0 -22
- data/docs/OrgsMembers200Response.md +0 -42
- data/docs/OrgsMembers200ResponseRowsInner.md +0 -24
- data/docs/OrgsOrgAssets200Response.md +0 -40
- data/docs/OrgsOrgAssets200ResponseRowsInner.md +0 -32
- data/docs/OrgsOrgCustomer200Response.md +0 -38
- data/docs/OrgsOrgCustomer200ResponseRowsInner.md +0 -18
- data/docs/OrgsOrgGleif200Response.md +0 -38
- data/docs/OrgsOrgGleif200ResponseRowsInner.md +0 -24
- data/docs/OrgsOrgHosted200Response.md +0 -38
- data/docs/OrgsOrgHosted200ResponseRowsInner.md +0 -22
- data/docs/OrgsOrgOwnedDrugs200Response.md +0 -40
- data/docs/OrgsOrgOwnedDrugs200ResponseRowsInner.md +0 -30
- data/docs/OrgsOrgOwnership200Response.md +0 -40
- data/docs/OrgsOrgOwnership200ResponseContext.md +0 -26
- data/docs/OrgsOrgOwnership200ResponseContextTruncated.md +0 -20
- data/docs/OrgsOrgPatentMentions200Response.md +0 -40
- data/docs/OrgsOrgPatentMentions200ResponseAttributionInner.md +0 -24
- data/docs/OrgsOrgPatentMentions200ResponseRowsInner.md +0 -28
- data/docs/OrgsOrgPeople200Response.md +0 -42
- data/docs/OrgsOrgPeople200ResponseContext.md +0 -18
- data/docs/OrgsOrgPeople200ResponseRowsInner.md +0 -26
- data/docs/OrgsOrgPipeline200Response.md +0 -42
- data/docs/OrgsOrgPipeline200ResponseContext.md +0 -20
- data/docs/OrgsOrgPipeline200ResponseContextCounts.md +0 -22
- data/docs/OrgsOrgPipeline200ResponseRowsInner.md +0 -28
- data/docs/OrgsOrgPrograms200Response.md +0 -44
- data/docs/OrgsOrgPrograms200ResponseContext.md +0 -20
- data/docs/OrgsOrgPrograms200ResponseRowsInner.md +0 -36
- data/docs/OrgsOrgPublications200Response.md +0 -40
- data/docs/OrgsOrgPublications200ResponseRowsInner.md +0 -22
- data/docs/OrgsOrgRecruitment200Response.md +0 -40
- data/docs/OrgsOrgRecruitment200ResponseContext.md +0 -58
- data/docs/OrgsOrgRecruitment200ResponseContextPredicted.md +0 -24
- data/docs/OrgsOrgRecruitment200ResponseContextRealized.md +0 -22
- data/docs/OrgsOrgRecruitment200ResponseContextStatuses.md +0 -32
- data/docs/OrgsOrgRelationships200Response.md +0 -42
- data/docs/OrgsOrgRelationships200ResponseQuery.md +0 -20
- data/docs/OrgsOrgSupplier200Response.md +0 -38
- data/docs/OrgsOrgSupplier200ResponseRowsInner.md +0 -26
- data/docs/OrgsOrgTargets200Response.md +0 -40
- data/docs/OrgsOrgTargets200ResponseRowsInner.md +0 -28
- data/docs/OrgsOrgTypeTally200Response.md +0 -40
- data/docs/OrgsOrgTypeTally200ResponseContext.md +0 -18
- data/docs/OrgsOrgTypeTally200ResponseRowsInner.md +0 -20
- data/docs/OrgsOrgUsPatents200Response.md +0 -42
- data/docs/OrgsOrgUsPatents200ResponseContext.md +0 -26
- data/docs/OrgsOrgUsPatents200ResponseRowsInner.md +0 -24
- data/docs/OrgsOverviewDigest200Response.md +0 -38
- data/docs/OrgsOverviewDigest200ResponseRowsInner.md +0 -24
- data/docs/OrgsOwnershipCoverage200Response.md +0 -38
- data/docs/OrgsOwnershipCoverage200ResponseRowsInner.md +0 -38
- data/docs/OrgsOwnershipHistory200Response.md +0 -42
- data/docs/OrgsOwnershipHistory200ResponseContext.md +0 -20
- data/docs/OrgsOwnershipHistory200ResponseRowsInner.md +0 -60
- data/docs/OrgsOwnershipPercentages200Response.md +0 -40
- data/docs/OrgsOwnershipPercentages200ResponseContext.md +0 -24
- data/docs/OrgsOwnershipPercentages200ResponseContextInsider.md +0 -40
- data/docs/OrgsOwnershipPercentages200ResponseContextInstitutional.md +0 -42
- data/docs/OrgsOwnershipPercentages200ResponseContextSharesOutstanding.md +0 -28
- data/docs/OrgsOwnershipPercentages200ResponseRowsInner.md +0 -30
- data/docs/OrgsOwnershipPercentages200ResponseRowsInnerAsOf.md +0 -49
- data/docs/OrgsPatentCliff200Response.md +0 -40
- data/docs/OrgsPatentCliff200ResponseContext.md +0 -18
- data/docs/OrgsPatentCliff200ResponseRowsInner.md +0 -36
- data/docs/OrgsPatentVsTrial200Response.md +0 -40
- data/docs/OrgsPatentVsTrial200ResponseContext.md +0 -24
- data/docs/OrgsPatentVsTrial200ResponseContextPortfolio.md +0 -24
- data/docs/OrgsPatentVsTrial200ResponseRowsInner.md +0 -22
- data/docs/OrgsPatents200Response.md +0 -40
- data/docs/OrgsPatents200ResponseContext.md +0 -22
- data/docs/OrgsPatents200ResponseRowsInner.md +0 -22
- data/docs/OrgsPdufaReconciliation200Response.md +0 -42
- data/docs/OrgsPdufaReconciliation200ResponseContext.md +0 -24
- data/docs/OrgsPdufaReconciliation200ResponseContextStatusCounts.md +0 -22
- data/docs/OrgsPdufaReconciliation200ResponseRowsInner.md +0 -32
- data/docs/OrgsPeers200Response.md +0 -38
- data/docs/OrgsPeers200ResponseRowsInner.md +0 -44
- data/docs/OrgsPhaseStatus200Response.md +0 -40
- data/docs/OrgsPhaseStatus200ResponseContext.md +0 -18
- data/docs/OrgsPhaseStatus200ResponseRowsInner.md +0 -26
- data/docs/OrgsPublishingBiomarkers200Response.md +0 -42
- data/docs/OrgsPublishingBiomarkers200ResponseContext.md +0 -22
- data/docs/OrgsPublishingBiomarkers200ResponseContextCoverage.md +0 -24
- data/docs/OrgsRareActivity200Response.md +0 -42
- data/docs/OrgsRareActivity200ResponseContext.md +0 -18
- data/docs/OrgsRareActivity200ResponseRowsInner.md +0 -40
- data/docs/OrgsRegistryShell200Response.md +0 -38
- data/docs/OrgsRegistryShell200ResponseRowsInner.md +0 -20
- data/docs/OrgsRelatedConditions200Response.md +0 -38
- data/docs/OrgsRelatedConditions200ResponseRowsInner.md +0 -20
- data/docs/OrgsRelatedUnfolded200Response.md +0 -42
- data/docs/OrgsRelatedUnfolded200ResponseRowsInner.md +0 -22
- data/docs/OrgsRevenueByDrug200Response.md +0 -40
- data/docs/OrgsRevenueByDrug200ResponseContext.md +0 -20
- data/docs/OrgsRevenueByDrug200ResponseRowsInner.md +0 -24
- data/docs/OrgsRevenueGeography200Response.md +0 -40
- data/docs/OrgsRevenueGeography200ResponseContext.md +0 -18
- data/docs/OrgsRevenueGeography200ResponseRowsInner.md +0 -26
- data/docs/OrgsSameNameSecFiler200Response.md +0 -38
- data/docs/OrgsSameNameSecFiler200ResponseRowsInner.md +0 -34
- data/docs/OrgsSbtiCrosscheck200Response.md +0 -40
- data/docs/OrgsSbtiCrosscheck200ResponseRowsInner.md +0 -20
- data/docs/OrgsScientistCom200Response.md +0 -40
- data/docs/OrgsScientistCom200ResponseContext.md +0 -18
- data/docs/OrgsScientistCom200ResponseRowsInner.md +0 -26
- data/docs/OrgsSecFilerShell200Response.md +0 -38
- data/docs/OrgsSecFilerShell200ResponseRowsInner.md +0 -22
- data/docs/OrgsSecFilerShell200ResponseRowsInnerValue.md +0 -55
- data/docs/OrgsSecFilerShell200ResponseRowsInnerValueOneOf.md +0 -34
- data/docs/OrgsSecPdufa200Response.md +0 -38
- data/docs/OrgsSecPdufa200ResponseRowsInner.md +0 -36
- data/docs/OrgsSupplierLinks200Response.md +0 -38
- data/docs/OrgsTimeline200Response.md +0 -42
- data/docs/OrgsTimeline200ResponseRowsInner.md +0 -34
- data/docs/OrgsTopConditions200Response.md +0 -38
- data/docs/OrgsTopConditions200ResponseRowsInner.md +0 -22
- data/docs/OrgsTopDrugs200Response.md +0 -38
- data/docs/OrgsTopDrugs200ResponseRowsInner.md +0 -20
- data/docs/OrgsTrialsPerYear200Response.md +0 -40
- data/docs/OrgsUnmatchedRevenue200Response.md +0 -40
- data/docs/OrgsUnmatchedRevenue200ResponseRowsInner.md +0 -22
- data/docs/OrgsUnmatchedRevenue200ResponseRowsInnerValue.md +0 -49
- data/lib/pharmaobservatory/api/orgs_api.rb +0 -5372
- data/lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_pagination.rb +0 -339
- data/lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_rows_inner.rb +0 -479
- data/lib/pharmaobservatory/models/biomarkers_cgi200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_coverage_by_traversal200_response_rows_inner.rb +0 -367
- data/lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response_context.rb +0 -239
- data/lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response_rows_inner.rb +0 -349
- data/lib/pharmaobservatory/models/biomarkers_fda_bqp200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_fda_cdx200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_get200_response.rb +0 -423
- data/lib/pharmaobservatory/models/biomarkers_get200_response_identity.rb +0 -267
- data/lib/pharmaobservatory/models/biomarkers_get200_response_identity_rows_inner.rb +0 -275
- data/lib/pharmaobservatory/models/biomarkers_get200_response_identity_rows_inner_value.rb +0 -105
- data/lib/pharmaobservatory/models/biomarkers_get200_response_resolution_confidence.rb +0 -263
- data/lib/pharmaobservatory/models/biomarkers_get200_response_sections_inner.rb +0 -417
- data/lib/pharmaobservatory/models/biomarkers_hub_tier_tables200_response_rows_inner.rb +0 -367
- data/lib/pharmaobservatory/models/biomarkers_identity200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_list200_response.rb +0 -538
- data/lib/pharmaobservatory/models/biomarkers_list200_response_build_state.rb +0 -275
- data/lib/pharmaobservatory/models/biomarkers_list200_response_columns_inner.rb +0 -289
- data/lib/pharmaobservatory/models/biomarkers_list200_response_facets_inner.rb +0 -291
- data/lib/pharmaobservatory/models/biomarkers_list200_response_facets_inner_options_inner.rb +0 -289
- data/lib/pharmaobservatory/models/biomarkers_list200_response_pagination.rb +0 -339
- data/lib/pharmaobservatory/models/biomarkers_list200_response_query.rb +0 -353
- data/lib/pharmaobservatory/models/biomarkers_literature200_response.rb +0 -524
- data/lib/pharmaobservatory/models/biomarkers_literature200_response_context.rb +0 -263
- data/lib/pharmaobservatory/models/biomarkers_ot_association200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_ot_association200_response_rows_inner.rb +0 -367
- data/lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response_attribution_inner.rb +0 -315
- data/lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response_rows_inner.rb +0 -385
- data/lib/pharmaobservatory/models/biomarkers_publishing_org200_response.rb +0 -524
- data/lib/pharmaobservatory/models/biomarkers_publishing_org200_response_context.rb +0 -315
- data/lib/pharmaobservatory/models/biomarkers_related_biomarkers200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/biomarkers_related_organizations200_response.rb +0 -489
- data/lib/pharmaobservatory/models/biomarkers_relations200_response.rb +0 -550
- data/lib/pharmaobservatory/models/biomarkers_relations200_response_context.rb +0 -263
- data/lib/pharmaobservatory/models/biomarkers_relations200_response_context_filters.rb +0 -315
- data/lib/pharmaobservatory/models/biomarkers_relations200_response_rows_inner.rb +0 -419
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response.rb +0 -524
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response_context.rb +0 -333
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response_rows_inner.rb +0 -484
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response_rows_inner_reference_screens.rb +0 -289
- data/lib/pharmaobservatory/models/biomarkers_trial_mention200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_trial_mention200_response_rows_inner.rb +0 -313
- data/lib/pharmaobservatory/models/biomarkers_variant_mentions200_response.rb +0 -515
- data/lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response.rb +0 -541
- data/lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response_query.rb +0 -237
- data/lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response_rows_inner.rb +0 -587
- data/lib/pharmaobservatory/models/biomarkers_where_it_appears200_response.rb +0 -489
- data/lib/pharmaobservatory/models/cell_lines_get200_response_identity_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/cell_lines_identity200_response.rb +0 -515
- data/lib/pharmaobservatory/models/cell_lines_list200_response.rb +0 -538
- data/lib/pharmaobservatory/models/cell_lines_list200_response_attribution_inner.rb +0 -341
- data/lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner_value.rb +0 -105
- data/lib/pharmaobservatory/models/cell_lines_status_counts200_response.rb +0 -475
- data/lib/pharmaobservatory/models/cell_lines_status_counts200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_active_programs200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_activity_summary200_response_rows_inner.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_approved_assets200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_approved_assets200_response_context.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_attribution_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_restriction.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_biomarker_capability200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_clia200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_climate200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_climate200_response_rows_inner.rb +0 -442
- data/lib/pharmaobservatory/models/orgs_collaborators200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_collaborators200_response_rows_inner.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_company200_response_rows_inner.rb +0 -1023
- data/lib/pharmaobservatory/models/orgs_competitors200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_competitors200_response_rows_inner.rb +0 -763
- data/lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner.rb +0 -275
- data/lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner_value.rb +0 -105
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response.rb +0 -555
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_attribution_inner.rb +0 -301
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_context.rb +0 -272
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_context_totals.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_rows_inner.rb +0 -849
- data/lib/pharmaobservatory/models/orgs_declarations200_response_rows_inner.rb +0 -503
- data/lib/pharmaobservatory/models/orgs_delivery200_response.rb +0 -503
- data/lib/pharmaobservatory/models/orgs_delivery200_response_rows_inner.rb +0 -391
- data/lib/pharmaobservatory/models/orgs_description200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_description200_response_rows_inner.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_disease_areas200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_disease_areas200_response_rows_inner.rb +0 -275
- data/lib/pharmaobservatory/models/orgs_diversity200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_diversity200_response_rows_inner.rb +0 -417
- data/lib/pharmaobservatory/models/orgs_esg_trend200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_esg_trend200_response_rows_inner.rb +0 -405
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response_context.rb +0 -291
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response_context_groups_inner.rb +0 -291
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response_rows_inner.rb +0 -367
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response_context.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner.rb +0 -275
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner_value.rb +0 -107
- data/lib/pharmaobservatory/models/orgs_financials200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_financials200_response_rows_inner.rb +0 -282
- data/lib/pharmaobservatory/models/orgs_funding200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_funding200_response_context.rb +0 -317
- data/lib/pharmaobservatory/models/orgs_funding200_response_context_summary.rb +0 -367
- data/lib/pharmaobservatory/models/orgs_funding200_response_rows_inner.rb +0 -381
- data/lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner.rb +0 -275
- data/lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner_value.rb +0 -108
- data/lib/pharmaobservatory/models/orgs_get200_response_sections_inner.rb +0 -417
- data/lib/pharmaobservatory/models/orgs_group_sections200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_group_sections200_response_context.rb +0 -369
- data/lib/pharmaobservatory/models/orgs_group_sections200_response_rows_inner.rb +0 -361
- data/lib/pharmaobservatory/models/orgs_group_structure200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_group_structure200_response_context.rb +0 -275
- data/lib/pharmaobservatory/models/orgs_gxp_sites200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_gxp_sites200_response_context.rb +0 -283
- data/lib/pharmaobservatory/models/orgs_gxp_sites200_response_context_group_companies_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_gxp_sites_map200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_identity200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_institutional13f200_response.rb +0 -555
- data/lib/pharmaobservatory/models/orgs_institutional13f200_response_context.rb +0 -291
- data/lib/pharmaobservatory/models/orgs_institutional13f200_response_rows_inner.rb +0 -684
- data/lib/pharmaobservatory/models/orgs_journals200_response.rb +0 -524
- data/lib/pharmaobservatory/models/orgs_list200_response.rb +0 -527
- data/lib/pharmaobservatory/models/orgs_list200_response_pagination.rb +0 -353
- data/lib/pharmaobservatory/models/orgs_list200_response_query.rb +0 -327
- data/lib/pharmaobservatory/models/orgs_list200_response_rows_inner.rb +0 -507
- data/lib/pharmaobservatory/models/orgs_member_children200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_member_identity200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_member_identity200_response_context_identifiers_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_member_identity200_response_rows_inner.rb +0 -341
- data/lib/pharmaobservatory/models/orgs_member_records200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_member_records200_response_context.rb +0 -239
- data/lib/pharmaobservatory/models/orgs_members200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_members200_response_rows_inner.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_org_assets200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_org_customer200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_org_gleif200_response_rows_inner.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_org_hosted200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_org_hosted200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_org_owned_drugs200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_org_owned_drugs200_response_rows_inner.rb +0 -395
- data/lib/pharmaobservatory/models/orgs_org_ownership200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_org_ownership200_response_context.rb +0 -324
- data/lib/pharmaobservatory/models/orgs_org_ownership200_response_context_truncated.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_org_patent_mentions200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_attribution_inner.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_rows_inner.rb +0 -367
- data/lib/pharmaobservatory/models/orgs_org_people200_response.rb +0 -555
- data/lib/pharmaobservatory/models/orgs_org_people200_response_context.rb +0 -237
- data/lib/pharmaobservatory/models/orgs_org_people200_response_rows_inner.rb +0 -341
- data/lib/pharmaobservatory/models/orgs_org_pipeline200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_org_pipeline200_response_context.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_org_pipeline200_response_context_counts.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_org_programs200_response.rb +0 -581
- data/lib/pharmaobservatory/models/orgs_org_programs200_response_context.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_org_programs200_response_rows_inner.rb +0 -471
- data/lib/pharmaobservatory/models/orgs_org_publications200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_org_publications200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context.rb +0 -757
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_predicted.rb +0 -259
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_realized.rb +0 -247
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_statuses.rb +0 -419
- data/lib/pharmaobservatory/models/orgs_org_relationships200_response.rb +0 -524
- data/lib/pharmaobservatory/models/orgs_org_relationships200_response_query.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_org_supplier200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_org_supplier200_response_rows_inner.rb +0 -285
- data/lib/pharmaobservatory/models/orgs_org_targets200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_org_type_tally200_response_context.rb +0 -237
- data/lib/pharmaobservatory/models/orgs_org_type_tally200_response_rows_inner.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_org_us_patents200_response.rb +0 -555
- data/lib/pharmaobservatory/models/orgs_org_us_patents200_response_context.rb +0 -327
- data/lib/pharmaobservatory/models/orgs_org_us_patents200_response_rows_inner.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_overview_digest200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_overview_digest200_response_rows_inner.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_ownership_coverage200_response.rb +0 -503
- data/lib/pharmaobservatory/models/orgs_ownership_coverage200_response_rows_inner.rb +0 -483
- data/lib/pharmaobservatory/models/orgs_ownership_history200_response.rb +0 -555
- data/lib/pharmaobservatory/models/orgs_ownership_history200_response_context.rb +0 -249
- data/lib/pharmaobservatory/models/orgs_ownership_history200_response_rows_inner.rb +0 -707
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_insider.rb +0 -495
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_institutional.rb +0 -521
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_shares_outstanding.rb +0 -367
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner.rb +0 -365
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner_as_of.rb +0 -105
- data/lib/pharmaobservatory/models/orgs_patent_cliff200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_patent_cliff200_response_context.rb +0 -237
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context_portfolio.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_patents200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_patents200_response_context.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_patents200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response.rb +0 -555
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context_status_counts.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_rows_inner.rb +0 -349
- data/lib/pharmaobservatory/models/orgs_peers200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_peers200_response_rows_inner.rb +0 -491
- data/lib/pharmaobservatory/models/orgs_phase_status200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_phase_status200_response_context.rb +0 -237
- data/lib/pharmaobservatory/models/orgs_phase_status200_response_rows_inner.rb +0 -341
- data/lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response.rb +0 -524
- data/lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context_coverage.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_rare_activity200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_rare_activity200_response_context.rb +0 -237
- data/lib/pharmaobservatory/models/orgs_rare_activity200_response_rows_inner.rb +0 -531
- data/lib/pharmaobservatory/models/orgs_registry_shell200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_registry_shell200_response_rows_inner.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_related_conditions200_response_rows_inner.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_related_unfolded200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_related_unfolded200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_revenue_by_drug200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_context.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_rows_inner.rb +0 -315
- data/lib/pharmaobservatory/models/orgs_revenue_geography200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_revenue_geography200_response_context.rb +0 -237
- data/lib/pharmaobservatory/models/orgs_revenue_geography200_response_rows_inner.rb +0 -327
- data/lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response_rows_inner.rb +0 -445
- data/lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response_rows_inner.rb +0 -263
- data/lib/pharmaobservatory/models/orgs_scientist_com200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_scientist_com200_response_context.rb +0 -237
- data/lib/pharmaobservatory/models/orgs_scientist_com200_response_rows_inner.rb +0 -343
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response.rb +0 -489
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner.rb +0 -275
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value.rb +0 -108
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value_one_of.rb +0 -419
- data/lib/pharmaobservatory/models/orgs_sec_pdufa200_response.rb +0 -503
- data/lib/pharmaobservatory/models/orgs_sec_pdufa200_response_rows_inner.rb +0 -457
- data/lib/pharmaobservatory/models/orgs_supplier_links200_response.rb +0 -475
- data/lib/pharmaobservatory/models/orgs_timeline200_response.rb +0 -541
- data/lib/pharmaobservatory/models/orgs_top_conditions200_response.rb +0 -503
- data/lib/pharmaobservatory/models/orgs_top_conditions200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_top_drugs200_response.rb +0 -503
- data/lib/pharmaobservatory/models/orgs_trials_per_year200_response.rb +0 -515
- data/lib/pharmaobservatory/models/orgs_unmatched_revenue200_response.rb +0 -529
- data/lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner.rb +0 -289
- data/lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner_value.rb +0 -105
metadata
CHANGED
|
@@ -1,14 +1,14 @@
|
|
|
1
1
|
--- !ruby/object:Gem::Specification
|
|
2
2
|
name: pharmaobservatory
|
|
3
3
|
version: !ruby/object:Gem::Version
|
|
4
|
-
version: 0.1.
|
|
4
|
+
version: 0.1.3
|
|
5
5
|
platform: ruby
|
|
6
6
|
authors:
|
|
7
7
|
- Scientist.com
|
|
8
8
|
autorequire:
|
|
9
9
|
bindir: bin
|
|
10
10
|
cert_chain: []
|
|
11
|
-
date: 2026-10-
|
|
11
|
+
date: 2026-10-19 00:00:00.000000000 Z
|
|
12
12
|
dependencies:
|
|
13
13
|
- !ruby/object:Gem::Dependency
|
|
14
14
|
name: faraday
|
|
@@ -90,615 +90,181 @@ files:
|
|
|
90
90
|
- docs/ApiV1BaseApi.md
|
|
91
91
|
- docs/ApiV1WhoamiGet200Response.md
|
|
92
92
|
- docs/AuthError.md
|
|
93
|
+
- docs/BiomarkerBqpAssertionsResponse.md
|
|
94
|
+
- docs/BiomarkerBqpAssertionsRow.md
|
|
95
|
+
- docs/BiomarkerCdxAssertionsResponse.md
|
|
96
|
+
- docs/BiomarkerCdxAssertionsResponseBuild.md
|
|
97
|
+
- docs/BiomarkerCdxAssertionsResponseFreshness.md
|
|
98
|
+
- docs/BiomarkerCdxAssertionsResponseScope.md
|
|
99
|
+
- docs/BiomarkerCdxAssertionsRow.md
|
|
100
|
+
- docs/BiomarkerEvidenceResponse.md
|
|
101
|
+
- docs/BiomarkerEvidenceRow.md
|
|
102
|
+
- docs/BiomarkerLiteratureResponse.md
|
|
103
|
+
- docs/BiomarkerLiteratureRow.md
|
|
104
|
+
- docs/BiomarkerPublishingCompaniesResponse.md
|
|
105
|
+
- docs/BiomarkerPublishingCompaniesRow.md
|
|
106
|
+
- docs/BiomarkerVariantMentionsResponse.md
|
|
107
|
+
- docs/BiomarkerVariantMentionsRow.md
|
|
93
108
|
- docs/BiomarkersApi.md
|
|
94
|
-
- docs/
|
|
95
|
-
- docs/
|
|
96
|
-
- docs/
|
|
97
|
-
- docs/BiomarkersAssayProviderLedger200ResponseRowsInner.md
|
|
98
|
-
- docs/BiomarkersCgi200Response.md
|
|
99
|
-
- docs/BiomarkersCgi200ResponseAttributionInner.md
|
|
100
|
-
- docs/BiomarkersCgi200ResponseRowsInner.md
|
|
101
|
-
- docs/BiomarkersCoverageByTraversal200Response.md
|
|
102
|
-
- docs/BiomarkersCoverageByTraversal200ResponseRowsInner.md
|
|
103
|
-
- docs/BiomarkersEvidenceOverTime200Response.md
|
|
104
|
-
- docs/BiomarkersEvidenceOverTime200ResponseContext.md
|
|
105
|
-
- docs/BiomarkersEvidenceOverTime200ResponseRowsInner.md
|
|
106
|
-
- docs/BiomarkersFdaBqp200Response.md
|
|
107
|
-
- docs/BiomarkersFdaBqp200ResponseRowsInner.md
|
|
108
|
-
- docs/BiomarkersFdaCdx200Response.md
|
|
109
|
-
- docs/BiomarkersFdaCdx200ResponseRowsInner.md
|
|
110
|
-
- docs/BiomarkersGet200Response.md
|
|
111
|
-
- docs/BiomarkersGet200ResponseIdentity.md
|
|
112
|
-
- docs/BiomarkersGet200ResponseIdentityRowsInner.md
|
|
113
|
-
- docs/BiomarkersGet200ResponseIdentityRowsInnerValue.md
|
|
114
|
-
- docs/BiomarkersGet200ResponseResolutionConfidence.md
|
|
115
|
-
- docs/BiomarkersGet200ResponseSectionsInner.md
|
|
116
|
-
- docs/BiomarkersHubTierTables200Response.md
|
|
117
|
-
- docs/BiomarkersHubTierTables200ResponseRowsInner.md
|
|
118
|
-
- docs/BiomarkersIdentity200Response.md
|
|
119
|
-
- docs/BiomarkersList200Response.md
|
|
120
|
-
- docs/BiomarkersList200ResponseAttributionInner.md
|
|
121
|
-
- docs/BiomarkersList200ResponseBuildState.md
|
|
122
|
-
- docs/BiomarkersList200ResponseColumnsInner.md
|
|
123
|
-
- docs/BiomarkersList200ResponseFacetsInner.md
|
|
124
|
-
- docs/BiomarkersList200ResponseFacetsInnerOptionsInner.md
|
|
125
|
-
- docs/BiomarkersList200ResponsePagination.md
|
|
126
|
-
- docs/BiomarkersList200ResponseQuery.md
|
|
127
|
-
- docs/BiomarkersList200ResponseQueryFilters.md
|
|
128
|
-
- docs/BiomarkersList200ResponseRowsInner.md
|
|
129
|
-
- docs/BiomarkersList200ResponseShape.md
|
|
130
|
-
- docs/BiomarkersLiterature200Response.md
|
|
131
|
-
- docs/BiomarkersLiterature200ResponseContext.md
|
|
132
|
-
- docs/BiomarkersLiterature200ResponseRowsInner.md
|
|
133
|
-
- docs/BiomarkersOtAssociation200Response.md
|
|
134
|
-
- docs/BiomarkersOtAssociation200ResponseRowsInner.md
|
|
135
|
-
- docs/BiomarkersPopulationAlleleFrequency200Response.md
|
|
136
|
-
- docs/BiomarkersPopulationAlleleFrequency200ResponseAttributionInner.md
|
|
137
|
-
- docs/BiomarkersPopulationAlleleFrequency200ResponseRowsInner.md
|
|
138
|
-
- docs/BiomarkersPublishingOrg200Response.md
|
|
139
|
-
- docs/BiomarkersPublishingOrg200ResponseContext.md
|
|
140
|
-
- docs/BiomarkersPublishingOrg200ResponseRowsInner.md
|
|
141
|
-
- docs/BiomarkersRelatedBiomarkers200Response.md
|
|
142
|
-
- docs/BiomarkersRelatedBiomarkers200ResponseRowsInner.md
|
|
143
|
-
- docs/BiomarkersRelatedConditions200Response.md
|
|
144
|
-
- docs/BiomarkersRelatedOrganizations200Response.md
|
|
145
|
-
- docs/BiomarkersRelations200Response.md
|
|
146
|
-
- docs/BiomarkersRelations200ResponseContext.md
|
|
147
|
-
- docs/BiomarkersRelations200ResponseContextFilters.md
|
|
148
|
-
- docs/BiomarkersRelations200ResponseQuery.md
|
|
149
|
-
- docs/BiomarkersRelations200ResponseRowsInner.md
|
|
150
|
-
- docs/BiomarkersRelations400Response.md
|
|
151
|
-
- docs/BiomarkersSampleScreening200Response.md
|
|
152
|
-
- docs/BiomarkersSampleScreening200ResponseContext.md
|
|
153
|
-
- docs/BiomarkersSampleScreening200ResponseContextCoverageCounts.md
|
|
154
|
-
- docs/BiomarkersSampleScreening200ResponseRowsInner.md
|
|
155
|
-
- docs/BiomarkersSampleScreening200ResponseRowsInnerReferenceScreens.md
|
|
156
|
-
- docs/BiomarkersTrialMention200Response.md
|
|
157
|
-
- docs/BiomarkersTrialMention200ResponseRowsInner.md
|
|
158
|
-
- docs/BiomarkersVariantMentions200Response.md
|
|
159
|
-
- docs/BiomarkersVariantMentions200ResponseRowsInner.md
|
|
160
|
-
- docs/BiomarkersVendorSourcing200Response.md
|
|
161
|
-
- docs/BiomarkersVendorSourcing200ResponseQuery.md
|
|
162
|
-
- docs/BiomarkersVendorSourcing200ResponseRowsInner.md
|
|
163
|
-
- docs/BiomarkersWhereItAppears200Response.md
|
|
164
|
-
- docs/BiomarkersWhereItAppears200ResponseRowsInner.md
|
|
109
|
+
- docs/BiomarkersRecord.md
|
|
110
|
+
- docs/BiomarkersResponse.md
|
|
111
|
+
- docs/BiomarkersRow.md
|
|
165
112
|
- docs/CellLinesApi.md
|
|
166
|
-
- docs/
|
|
167
|
-
- docs/
|
|
168
|
-
- docs/
|
|
169
|
-
- docs/
|
|
170
|
-
- docs/
|
|
171
|
-
- docs/
|
|
172
|
-
- docs/
|
|
173
|
-
- docs/
|
|
174
|
-
- docs/
|
|
175
|
-
- docs/
|
|
176
|
-
- docs/
|
|
177
|
-
- docs/
|
|
178
|
-
- docs/
|
|
179
|
-
- docs/
|
|
180
|
-
- docs/
|
|
181
|
-
- docs/
|
|
182
|
-
- docs/
|
|
183
|
-
- docs/
|
|
184
|
-
- docs/
|
|
185
|
-
- docs/
|
|
186
|
-
- docs/
|
|
187
|
-
- docs/
|
|
188
|
-
- docs/
|
|
189
|
-
- docs/
|
|
190
|
-
- docs/
|
|
191
|
-
- docs/
|
|
192
|
-
- docs/
|
|
193
|
-
- docs/
|
|
194
|
-
- docs/
|
|
195
|
-
- docs/
|
|
196
|
-
- docs/
|
|
197
|
-
- docs/
|
|
198
|
-
- docs/
|
|
199
|
-
- docs/
|
|
200
|
-
- docs/
|
|
201
|
-
- docs/
|
|
202
|
-
- docs/
|
|
203
|
-
- docs/
|
|
204
|
-
- docs/
|
|
205
|
-
- docs/
|
|
206
|
-
- docs/
|
|
207
|
-
- docs/
|
|
208
|
-
- docs/
|
|
209
|
-
- docs/
|
|
210
|
-
- docs/
|
|
211
|
-
- docs/
|
|
212
|
-
- docs/
|
|
213
|
-
- docs/
|
|
214
|
-
- docs/
|
|
215
|
-
- docs/
|
|
216
|
-
- docs/
|
|
217
|
-
- docs/
|
|
218
|
-
- docs/
|
|
219
|
-
- docs/
|
|
220
|
-
- docs/
|
|
221
|
-
- docs/
|
|
222
|
-
- docs/
|
|
223
|
-
- docs/
|
|
224
|
-
- docs/
|
|
225
|
-
- docs/
|
|
226
|
-
- docs/
|
|
227
|
-
- docs/
|
|
228
|
-
- docs/
|
|
229
|
-
- docs/
|
|
230
|
-
- docs/OrgsFinancialOverview200ResponseRowsInnerValue.md
|
|
231
|
-
- docs/OrgsFinancials200Response.md
|
|
232
|
-
- docs/OrgsFinancials200ResponseRowsInner.md
|
|
233
|
-
- docs/OrgsFunding200Response.md
|
|
234
|
-
- docs/OrgsFunding200ResponseContext.md
|
|
235
|
-
- docs/OrgsFunding200ResponseContextSummary.md
|
|
236
|
-
- docs/OrgsFunding200ResponseRowsInner.md
|
|
237
|
-
- docs/OrgsGet200Response.md
|
|
238
|
-
- docs/OrgsGet200ResponseIdentity.md
|
|
239
|
-
- docs/OrgsGet200ResponseIdentityRowsInner.md
|
|
240
|
-
- docs/OrgsGet200ResponseIdentityRowsInnerValue.md
|
|
241
|
-
- docs/OrgsGet200ResponseSectionsInner.md
|
|
242
|
-
- docs/OrgsGroupSections200Response.md
|
|
243
|
-
- docs/OrgsGroupSections200ResponseContext.md
|
|
244
|
-
- docs/OrgsGroupSections200ResponseRowsInner.md
|
|
245
|
-
- docs/OrgsGroupStructure200Response.md
|
|
246
|
-
- docs/OrgsGroupStructure200ResponseContext.md
|
|
247
|
-
- docs/OrgsGroupStructure200ResponseRowsInner.md
|
|
248
|
-
- docs/OrgsGxpSites200Response.md
|
|
249
|
-
- docs/OrgsGxpSites200ResponseContext.md
|
|
250
|
-
- docs/OrgsGxpSites200ResponseContextGroupCompaniesInner.md
|
|
251
|
-
- docs/OrgsGxpSites200ResponseRowsInner.md
|
|
252
|
-
- docs/OrgsGxpSitesMap200Response.md
|
|
253
|
-
- docs/OrgsIdentity200Response.md
|
|
254
|
-
- docs/OrgsImportRefusals200Response.md
|
|
255
|
-
- docs/OrgsInstitutional13f200Response.md
|
|
256
|
-
- docs/OrgsInstitutional13f200ResponseContext.md
|
|
257
|
-
- docs/OrgsInstitutional13f200ResponseRowsInner.md
|
|
258
|
-
- docs/OrgsJournals200Response.md
|
|
259
|
-
- docs/OrgsList200Response.md
|
|
260
|
-
- docs/OrgsList200ResponsePagination.md
|
|
261
|
-
- docs/OrgsList200ResponseQuery.md
|
|
262
|
-
- docs/OrgsList200ResponseRowsInner.md
|
|
263
|
-
- docs/OrgsMemberChildren200Response.md
|
|
264
|
-
- docs/OrgsMemberIdentity200Response.md
|
|
265
|
-
- docs/OrgsMemberIdentity200ResponseContext.md
|
|
266
|
-
- docs/OrgsMemberIdentity200ResponseContextIdentifiersInner.md
|
|
267
|
-
- docs/OrgsMemberIdentity200ResponseContextParent.md
|
|
268
|
-
- docs/OrgsMemberIdentity200ResponseRowsInner.md
|
|
269
|
-
- docs/OrgsMemberRecords200Response.md
|
|
270
|
-
- docs/OrgsMemberRecords200ResponseContext.md
|
|
271
|
-
- docs/OrgsMemberRecords200ResponseRowsInner.md
|
|
272
|
-
- docs/OrgsMembers200Response.md
|
|
273
|
-
- docs/OrgsMembers200ResponseRowsInner.md
|
|
274
|
-
- docs/OrgsOrgAssets200Response.md
|
|
275
|
-
- docs/OrgsOrgAssets200ResponseRowsInner.md
|
|
276
|
-
- docs/OrgsOrgCustomer200Response.md
|
|
277
|
-
- docs/OrgsOrgCustomer200ResponseRowsInner.md
|
|
278
|
-
- docs/OrgsOrgGleif200Response.md
|
|
279
|
-
- docs/OrgsOrgGleif200ResponseRowsInner.md
|
|
280
|
-
- docs/OrgsOrgHosted200Response.md
|
|
281
|
-
- docs/OrgsOrgHosted200ResponseRowsInner.md
|
|
282
|
-
- docs/OrgsOrgOwnedDrugs200Response.md
|
|
283
|
-
- docs/OrgsOrgOwnedDrugs200ResponseRowsInner.md
|
|
284
|
-
- docs/OrgsOrgOwnership200Response.md
|
|
285
|
-
- docs/OrgsOrgOwnership200ResponseContext.md
|
|
286
|
-
- docs/OrgsOrgOwnership200ResponseContextTruncated.md
|
|
287
|
-
- docs/OrgsOrgPatentMentions200Response.md
|
|
288
|
-
- docs/OrgsOrgPatentMentions200ResponseAttributionInner.md
|
|
289
|
-
- docs/OrgsOrgPatentMentions200ResponseRowsInner.md
|
|
290
|
-
- docs/OrgsOrgPeople200Response.md
|
|
291
|
-
- docs/OrgsOrgPeople200ResponseContext.md
|
|
292
|
-
- docs/OrgsOrgPeople200ResponseRowsInner.md
|
|
293
|
-
- docs/OrgsOrgPipeline200Response.md
|
|
294
|
-
- docs/OrgsOrgPipeline200ResponseContext.md
|
|
295
|
-
- docs/OrgsOrgPipeline200ResponseContextCounts.md
|
|
296
|
-
- docs/OrgsOrgPipeline200ResponseRowsInner.md
|
|
297
|
-
- docs/OrgsOrgPrograms200Response.md
|
|
298
|
-
- docs/OrgsOrgPrograms200ResponseContext.md
|
|
299
|
-
- docs/OrgsOrgPrograms200ResponseRowsInner.md
|
|
300
|
-
- docs/OrgsOrgPublications200Response.md
|
|
301
|
-
- docs/OrgsOrgPublications200ResponseRowsInner.md
|
|
302
|
-
- docs/OrgsOrgRecruitment200Response.md
|
|
303
|
-
- docs/OrgsOrgRecruitment200ResponseContext.md
|
|
304
|
-
- docs/OrgsOrgRecruitment200ResponseContextPredicted.md
|
|
305
|
-
- docs/OrgsOrgRecruitment200ResponseContextRealized.md
|
|
306
|
-
- docs/OrgsOrgRecruitment200ResponseContextStatuses.md
|
|
307
|
-
- docs/OrgsOrgRelationships200Response.md
|
|
308
|
-
- docs/OrgsOrgRelationships200ResponseQuery.md
|
|
309
|
-
- docs/OrgsOrgSupplier200Response.md
|
|
310
|
-
- docs/OrgsOrgSupplier200ResponseRowsInner.md
|
|
311
|
-
- docs/OrgsOrgTargets200Response.md
|
|
312
|
-
- docs/OrgsOrgTargets200ResponseRowsInner.md
|
|
313
|
-
- docs/OrgsOrgTypeTally200Response.md
|
|
314
|
-
- docs/OrgsOrgTypeTally200ResponseContext.md
|
|
315
|
-
- docs/OrgsOrgTypeTally200ResponseRowsInner.md
|
|
316
|
-
- docs/OrgsOrgUsPatents200Response.md
|
|
317
|
-
- docs/OrgsOrgUsPatents200ResponseContext.md
|
|
318
|
-
- docs/OrgsOrgUsPatents200ResponseRowsInner.md
|
|
319
|
-
- docs/OrgsOverviewDigest200Response.md
|
|
320
|
-
- docs/OrgsOverviewDigest200ResponseRowsInner.md
|
|
321
|
-
- docs/OrgsOwnershipCoverage200Response.md
|
|
322
|
-
- docs/OrgsOwnershipCoverage200ResponseRowsInner.md
|
|
323
|
-
- docs/OrgsOwnershipHistory200Response.md
|
|
324
|
-
- docs/OrgsOwnershipHistory200ResponseContext.md
|
|
325
|
-
- docs/OrgsOwnershipHistory200ResponseRowsInner.md
|
|
326
|
-
- docs/OrgsOwnershipPercentages200Response.md
|
|
327
|
-
- docs/OrgsOwnershipPercentages200ResponseContext.md
|
|
328
|
-
- docs/OrgsOwnershipPercentages200ResponseContextInsider.md
|
|
329
|
-
- docs/OrgsOwnershipPercentages200ResponseContextInstitutional.md
|
|
330
|
-
- docs/OrgsOwnershipPercentages200ResponseContextSharesOutstanding.md
|
|
331
|
-
- docs/OrgsOwnershipPercentages200ResponseRowsInner.md
|
|
332
|
-
- docs/OrgsOwnershipPercentages200ResponseRowsInnerAsOf.md
|
|
333
|
-
- docs/OrgsPatentCliff200Response.md
|
|
334
|
-
- docs/OrgsPatentCliff200ResponseContext.md
|
|
335
|
-
- docs/OrgsPatentCliff200ResponseRowsInner.md
|
|
336
|
-
- docs/OrgsPatentVsTrial200Response.md
|
|
337
|
-
- docs/OrgsPatentVsTrial200ResponseContext.md
|
|
338
|
-
- docs/OrgsPatentVsTrial200ResponseContextPortfolio.md
|
|
339
|
-
- docs/OrgsPatentVsTrial200ResponseRowsInner.md
|
|
340
|
-
- docs/OrgsPatents200Response.md
|
|
341
|
-
- docs/OrgsPatents200ResponseContext.md
|
|
342
|
-
- docs/OrgsPatents200ResponseRowsInner.md
|
|
343
|
-
- docs/OrgsPdufaReconciliation200Response.md
|
|
344
|
-
- docs/OrgsPdufaReconciliation200ResponseContext.md
|
|
345
|
-
- docs/OrgsPdufaReconciliation200ResponseContextStatusCounts.md
|
|
346
|
-
- docs/OrgsPdufaReconciliation200ResponseRowsInner.md
|
|
347
|
-
- docs/OrgsPeers200Response.md
|
|
348
|
-
- docs/OrgsPeers200ResponseRowsInner.md
|
|
349
|
-
- docs/OrgsPhaseStatus200Response.md
|
|
350
|
-
- docs/OrgsPhaseStatus200ResponseContext.md
|
|
351
|
-
- docs/OrgsPhaseStatus200ResponseRowsInner.md
|
|
352
|
-
- docs/OrgsPublishingBiomarkers200Response.md
|
|
353
|
-
- docs/OrgsPublishingBiomarkers200ResponseContext.md
|
|
354
|
-
- docs/OrgsPublishingBiomarkers200ResponseContextCoverage.md
|
|
355
|
-
- docs/OrgsRareActivity200Response.md
|
|
356
|
-
- docs/OrgsRareActivity200ResponseContext.md
|
|
357
|
-
- docs/OrgsRareActivity200ResponseRowsInner.md
|
|
358
|
-
- docs/OrgsRegistryShell200Response.md
|
|
359
|
-
- docs/OrgsRegistryShell200ResponseRowsInner.md
|
|
360
|
-
- docs/OrgsRelatedConditions200Response.md
|
|
361
|
-
- docs/OrgsRelatedConditions200ResponseRowsInner.md
|
|
362
|
-
- docs/OrgsRelatedUnfolded200Response.md
|
|
363
|
-
- docs/OrgsRelatedUnfolded200ResponseRowsInner.md
|
|
364
|
-
- docs/OrgsRevenueByDrug200Response.md
|
|
365
|
-
- docs/OrgsRevenueByDrug200ResponseContext.md
|
|
366
|
-
- docs/OrgsRevenueByDrug200ResponseRowsInner.md
|
|
367
|
-
- docs/OrgsRevenueGeography200Response.md
|
|
368
|
-
- docs/OrgsRevenueGeography200ResponseContext.md
|
|
369
|
-
- docs/OrgsRevenueGeography200ResponseRowsInner.md
|
|
370
|
-
- docs/OrgsSameNameSecFiler200Response.md
|
|
371
|
-
- docs/OrgsSameNameSecFiler200ResponseRowsInner.md
|
|
372
|
-
- docs/OrgsSbtiCrosscheck200Response.md
|
|
373
|
-
- docs/OrgsSbtiCrosscheck200ResponseRowsInner.md
|
|
374
|
-
- docs/OrgsScientistCom200Response.md
|
|
375
|
-
- docs/OrgsScientistCom200ResponseContext.md
|
|
376
|
-
- docs/OrgsScientistCom200ResponseRowsInner.md
|
|
377
|
-
- docs/OrgsSecFilerShell200Response.md
|
|
378
|
-
- docs/OrgsSecFilerShell200ResponseRowsInner.md
|
|
379
|
-
- docs/OrgsSecFilerShell200ResponseRowsInnerValue.md
|
|
380
|
-
- docs/OrgsSecFilerShell200ResponseRowsInnerValueOneOf.md
|
|
381
|
-
- docs/OrgsSecPdufa200Response.md
|
|
382
|
-
- docs/OrgsSecPdufa200ResponseRowsInner.md
|
|
383
|
-
- docs/OrgsSupplierLinks200Response.md
|
|
384
|
-
- docs/OrgsTimeline200Response.md
|
|
385
|
-
- docs/OrgsTimeline200ResponseRowsInner.md
|
|
386
|
-
- docs/OrgsTopConditions200Response.md
|
|
387
|
-
- docs/OrgsTopConditions200ResponseRowsInner.md
|
|
388
|
-
- docs/OrgsTopDrugs200Response.md
|
|
389
|
-
- docs/OrgsTopDrugs200ResponseRowsInner.md
|
|
390
|
-
- docs/OrgsTrialsPerYear200Response.md
|
|
391
|
-
- docs/OrgsUnmatchedRevenue200Response.md
|
|
392
|
-
- docs/OrgsUnmatchedRevenue200ResponseRowsInner.md
|
|
393
|
-
- docs/OrgsUnmatchedRevenue200ResponseRowsInnerValue.md
|
|
113
|
+
- docs/CellLinesRecord.md
|
|
114
|
+
- docs/CellLinesResponse.md
|
|
115
|
+
- docs/CellLinesRow.md
|
|
116
|
+
- docs/CompaniesApi.md
|
|
117
|
+
- docs/CompaniesRecord.md
|
|
118
|
+
- docs/CompaniesResponse.md
|
|
119
|
+
- docs/CompaniesRow.md
|
|
120
|
+
- docs/CompanyMembersResponse.md
|
|
121
|
+
- docs/CompanyMembersRow.md
|
|
122
|
+
- docs/CompanyProgramsResponse.md
|
|
123
|
+
- docs/CompanyProgramsRow.md
|
|
124
|
+
- docs/CompanyTargetsResponse.md
|
|
125
|
+
- docs/CompanyTargetsRow.md
|
|
126
|
+
- docs/DatasetAttribution.md
|
|
127
|
+
- docs/DatasetBuildState.md
|
|
128
|
+
- docs/DatasetColumn.md
|
|
129
|
+
- docs/DatasetListing.md
|
|
130
|
+
- docs/DatasetSummaryList.md
|
|
131
|
+
- docs/DatasetSummaryListDatasetsInner.md
|
|
132
|
+
- docs/DatasetsApi.md
|
|
133
|
+
- docs/DrugPatentCliffResponse.md
|
|
134
|
+
- docs/DrugPatentCliffRow.md
|
|
135
|
+
- docs/InstitutionalHoldingsResponse.md
|
|
136
|
+
- docs/InstitutionalHoldingsRow.md
|
|
137
|
+
- docs/LegalEntitiesApi.md
|
|
138
|
+
- docs/LegalEntitiesRecord.md
|
|
139
|
+
- docs/LegalEntitiesRecordAttributes.md
|
|
140
|
+
- docs/LegalEntitiesResponse.md
|
|
141
|
+
- docs/LegalEntitiesRow.md
|
|
142
|
+
- docs/PdufaDatesResponse.md
|
|
143
|
+
- docs/PdufaDatesRow.md
|
|
144
|
+
- docs/QueryApi.md
|
|
145
|
+
- docs/QueryError.md
|
|
146
|
+
- docs/QueryResponse.md
|
|
147
|
+
- docs/QueryResponseColumnsInner.md
|
|
148
|
+
- docs/QueryRunRequest.md
|
|
149
|
+
- docs/ResultPage.md
|
|
150
|
+
- docs/SiteBedsYearlyResponse.md
|
|
151
|
+
- docs/SiteBedsYearlyRow.md
|
|
152
|
+
- docs/SiteCroTrialsResponse.md
|
|
153
|
+
- docs/SiteCroTrialsRow.md
|
|
154
|
+
- docs/SiteHospitalsResponse.md
|
|
155
|
+
- docs/SiteHospitalsRow.md
|
|
156
|
+
- docs/SiteInvestigatorsResponse.md
|
|
157
|
+
- docs/SiteInvestigatorsRow.md
|
|
158
|
+
- docs/SiteTrialConditionsResponse.md
|
|
159
|
+
- docs/SiteTrialConditionsRow.md
|
|
160
|
+
- docs/SiteTrialDrugsResponse.md
|
|
161
|
+
- docs/SiteTrialDrugsRow.md
|
|
162
|
+
- docs/SiteTrialsResponse.md
|
|
163
|
+
- docs/SiteTrialsRow.md
|
|
164
|
+
- docs/SitesApi.md
|
|
165
|
+
- docs/SitesRecord.md
|
|
166
|
+
- docs/SitesRecordAttributes.md
|
|
167
|
+
- docs/SitesResponse.md
|
|
168
|
+
- docs/SitesRow.md
|
|
169
|
+
- docs/SponsorRecruitmentByPhaseResponse.md
|
|
170
|
+
- docs/SponsorRecruitmentByPhaseRow.md
|
|
171
|
+
- docs/SponsorRecruitmentDurationResponse.md
|
|
172
|
+
- docs/SponsorRecruitmentDurationRow.md
|
|
173
|
+
- docs/SponsorTrialStartForecastResponse.md
|
|
174
|
+
- docs/SponsorTrialStartForecastRow.md
|
|
175
|
+
- docs/SponsorTrialsResponse.md
|
|
176
|
+
- docs/SponsorTrialsRow.md
|
|
394
177
|
- lib/pharmaobservatory.rb
|
|
395
178
|
- lib/pharmaobservatory/api/api_v1_base_api.rb
|
|
396
179
|
- lib/pharmaobservatory/api/biomarkers_api.rb
|
|
397
180
|
- lib/pharmaobservatory/api/cell_lines_api.rb
|
|
398
|
-
- lib/pharmaobservatory/api/
|
|
181
|
+
- lib/pharmaobservatory/api/companies_api.rb
|
|
182
|
+
- lib/pharmaobservatory/api/datasets_api.rb
|
|
183
|
+
- lib/pharmaobservatory/api/legal_entities_api.rb
|
|
184
|
+
- lib/pharmaobservatory/api/query_api.rb
|
|
185
|
+
- lib/pharmaobservatory/api/sites_api.rb
|
|
399
186
|
- lib/pharmaobservatory/api_client.rb
|
|
400
187
|
- lib/pharmaobservatory/api_error.rb
|
|
401
188
|
- lib/pharmaobservatory/configuration.rb
|
|
402
189
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb
|
|
403
190
|
- lib/pharmaobservatory/models/auth_error.rb
|
|
404
|
-
- lib/pharmaobservatory/models/
|
|
405
|
-
- lib/pharmaobservatory/models/
|
|
406
|
-
- lib/pharmaobservatory/models/
|
|
407
|
-
- lib/pharmaobservatory/models/
|
|
408
|
-
- lib/pharmaobservatory/models/
|
|
409
|
-
- lib/pharmaobservatory/models/
|
|
410
|
-
- lib/pharmaobservatory/models/
|
|
411
|
-
- lib/pharmaobservatory/models/
|
|
412
|
-
- lib/pharmaobservatory/models/
|
|
413
|
-
- lib/pharmaobservatory/models/
|
|
414
|
-
- lib/pharmaobservatory/models/
|
|
415
|
-
- lib/pharmaobservatory/models/
|
|
416
|
-
- lib/pharmaobservatory/models/
|
|
417
|
-
- lib/pharmaobservatory/models/
|
|
418
|
-
- lib/pharmaobservatory/models/
|
|
419
|
-
- lib/pharmaobservatory/models/
|
|
420
|
-
- lib/pharmaobservatory/models/
|
|
421
|
-
- lib/pharmaobservatory/models/
|
|
422
|
-
- lib/pharmaobservatory/models/
|
|
423
|
-
- lib/pharmaobservatory/models/
|
|
424
|
-
- lib/pharmaobservatory/models/
|
|
425
|
-
- lib/pharmaobservatory/models/
|
|
426
|
-
- lib/pharmaobservatory/models/
|
|
427
|
-
- lib/pharmaobservatory/models/
|
|
428
|
-
- lib/pharmaobservatory/models/
|
|
429
|
-
- lib/pharmaobservatory/models/
|
|
430
|
-
- lib/pharmaobservatory/models/
|
|
431
|
-
- lib/pharmaobservatory/models/
|
|
432
|
-
- lib/pharmaobservatory/models/
|
|
433
|
-
- lib/pharmaobservatory/models/
|
|
434
|
-
- lib/pharmaobservatory/models/
|
|
435
|
-
- lib/pharmaobservatory/models/
|
|
436
|
-
- lib/pharmaobservatory/models/
|
|
437
|
-
- lib/pharmaobservatory/models/
|
|
438
|
-
- lib/pharmaobservatory/models/
|
|
439
|
-
- lib/pharmaobservatory/models/
|
|
440
|
-
- lib/pharmaobservatory/models/
|
|
441
|
-
- lib/pharmaobservatory/models/
|
|
442
|
-
- lib/pharmaobservatory/models/
|
|
443
|
-
- lib/pharmaobservatory/models/
|
|
444
|
-
- lib/pharmaobservatory/models/
|
|
445
|
-
- lib/pharmaobservatory/models/
|
|
446
|
-
- lib/pharmaobservatory/models/
|
|
447
|
-
- lib/pharmaobservatory/models/
|
|
448
|
-
- lib/pharmaobservatory/models/
|
|
449
|
-
- lib/pharmaobservatory/models/
|
|
450
|
-
- lib/pharmaobservatory/models/
|
|
451
|
-
- lib/pharmaobservatory/models/
|
|
452
|
-
- lib/pharmaobservatory/models/
|
|
453
|
-
- lib/pharmaobservatory/models/
|
|
454
|
-
- lib/pharmaobservatory/models/
|
|
455
|
-
- lib/pharmaobservatory/models/
|
|
456
|
-
- lib/pharmaobservatory/models/
|
|
457
|
-
- lib/pharmaobservatory/models/
|
|
458
|
-
- lib/pharmaobservatory/models/
|
|
459
|
-
- lib/pharmaobservatory/models/
|
|
460
|
-
- lib/pharmaobservatory/models/
|
|
461
|
-
- lib/pharmaobservatory/models/
|
|
462
|
-
- lib/pharmaobservatory/models/
|
|
463
|
-
- lib/pharmaobservatory/models/
|
|
464
|
-
- lib/pharmaobservatory/models/
|
|
465
|
-
- lib/pharmaobservatory/models/
|
|
466
|
-
- lib/pharmaobservatory/models/
|
|
467
|
-
- lib/pharmaobservatory/models/
|
|
468
|
-
- lib/pharmaobservatory/models/
|
|
469
|
-
- lib/pharmaobservatory/models/
|
|
470
|
-
- lib/pharmaobservatory/models/
|
|
471
|
-
- lib/pharmaobservatory/models/
|
|
472
|
-
- lib/pharmaobservatory/models/
|
|
473
|
-
- lib/pharmaobservatory/models/
|
|
474
|
-
- lib/pharmaobservatory/models/
|
|
475
|
-
- lib/pharmaobservatory/models/
|
|
476
|
-
- lib/pharmaobservatory/models/
|
|
477
|
-
- lib/pharmaobservatory/models/
|
|
478
|
-
- lib/pharmaobservatory/models/
|
|
479
|
-
- lib/pharmaobservatory/models/
|
|
480
|
-
- lib/pharmaobservatory/models/
|
|
481
|
-
- lib/pharmaobservatory/models/cell_lines_list200_response_query.rb
|
|
482
|
-
- lib/pharmaobservatory/models/cell_lines_list200_response_query_filters.rb
|
|
483
|
-
- lib/pharmaobservatory/models/cell_lines_list200_response_rows_inner.rb
|
|
484
|
-
- lib/pharmaobservatory/models/cell_lines_safety_resolution200_response.rb
|
|
485
|
-
- lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner.rb
|
|
486
|
-
- lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner_value.rb
|
|
487
|
-
- lib/pharmaobservatory/models/cell_lines_status_counts200_response.rb
|
|
488
|
-
- lib/pharmaobservatory/models/cell_lines_status_counts200_response_rows_inner.rb
|
|
489
|
-
- lib/pharmaobservatory/models/not_entitled_error.rb
|
|
490
|
-
- lib/pharmaobservatory/models/orgs_active_programs200_response.rb
|
|
491
|
-
- lib/pharmaobservatory/models/orgs_activity_summary200_response.rb
|
|
492
|
-
- lib/pharmaobservatory/models/orgs_activity_summary200_response_rows_inner.rb
|
|
493
|
-
- lib/pharmaobservatory/models/orgs_approved_assets200_response.rb
|
|
494
|
-
- lib/pharmaobservatory/models/orgs_approved_assets200_response_context.rb
|
|
495
|
-
- lib/pharmaobservatory/models/orgs_approved_assets200_response_rows_inner.rb
|
|
496
|
-
- lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response.rb
|
|
497
|
-
- lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_attribution_inner.rb
|
|
498
|
-
- lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_restriction.rb
|
|
499
|
-
- lib/pharmaobservatory/models/orgs_biomarker_capability200_response.rb
|
|
500
|
-
- lib/pharmaobservatory/models/orgs_clia200_response.rb
|
|
501
|
-
- lib/pharmaobservatory/models/orgs_climate200_response.rb
|
|
502
|
-
- lib/pharmaobservatory/models/orgs_climate200_response_rows_inner.rb
|
|
503
|
-
- lib/pharmaobservatory/models/orgs_collaborators200_response.rb
|
|
504
|
-
- lib/pharmaobservatory/models/orgs_collaborators200_response_rows_inner.rb
|
|
505
|
-
- lib/pharmaobservatory/models/orgs_company200_response.rb
|
|
506
|
-
- lib/pharmaobservatory/models/orgs_company200_response_rows_inner.rb
|
|
507
|
-
- lib/pharmaobservatory/models/orgs_competitors200_response.rb
|
|
508
|
-
- lib/pharmaobservatory/models/orgs_competitors200_response_rows_inner.rb
|
|
509
|
-
- lib/pharmaobservatory/models/orgs_coverage200_response.rb
|
|
510
|
-
- lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner.rb
|
|
511
|
-
- lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner_value.rb
|
|
512
|
-
- lib/pharmaobservatory/models/orgs_current_ownership200_response.rb
|
|
513
|
-
- lib/pharmaobservatory/models/orgs_current_ownership200_response_attribution_inner.rb
|
|
514
|
-
- lib/pharmaobservatory/models/orgs_current_ownership200_response_context.rb
|
|
515
|
-
- lib/pharmaobservatory/models/orgs_current_ownership200_response_context_totals.rb
|
|
516
|
-
- lib/pharmaobservatory/models/orgs_current_ownership200_response_rows_inner.rb
|
|
517
|
-
- lib/pharmaobservatory/models/orgs_declarations200_response.rb
|
|
518
|
-
- lib/pharmaobservatory/models/orgs_declarations200_response_rows_inner.rb
|
|
519
|
-
- lib/pharmaobservatory/models/orgs_delivery200_response.rb
|
|
520
|
-
- lib/pharmaobservatory/models/orgs_delivery200_response_rows_inner.rb
|
|
521
|
-
- lib/pharmaobservatory/models/orgs_description200_response.rb
|
|
522
|
-
- lib/pharmaobservatory/models/orgs_description200_response_rows_inner.rb
|
|
523
|
-
- lib/pharmaobservatory/models/orgs_disease_areas200_response.rb
|
|
524
|
-
- lib/pharmaobservatory/models/orgs_disease_areas200_response_rows_inner.rb
|
|
525
|
-
- lib/pharmaobservatory/models/orgs_diversity200_response.rb
|
|
526
|
-
- lib/pharmaobservatory/models/orgs_diversity200_response_rows_inner.rb
|
|
527
|
-
- lib/pharmaobservatory/models/orgs_esg_trend200_response.rb
|
|
528
|
-
- lib/pharmaobservatory/models/orgs_esg_trend200_response_attribution_inner.rb
|
|
529
|
-
- lib/pharmaobservatory/models/orgs_esg_trend200_response_context.rb
|
|
530
|
-
- lib/pharmaobservatory/models/orgs_esg_trend200_response_rows_inner.rb
|
|
531
|
-
- lib/pharmaobservatory/models/orgs_financial_line_items200_response.rb
|
|
532
|
-
- lib/pharmaobservatory/models/orgs_financial_line_items200_response_context.rb
|
|
533
|
-
- lib/pharmaobservatory/models/orgs_financial_line_items200_response_context_groups_inner.rb
|
|
534
|
-
- lib/pharmaobservatory/models/orgs_financial_line_items200_response_rows_inner.rb
|
|
535
|
-
- lib/pharmaobservatory/models/orgs_financial_overview200_response.rb
|
|
536
|
-
- lib/pharmaobservatory/models/orgs_financial_overview200_response_context.rb
|
|
537
|
-
- lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner.rb
|
|
538
|
-
- lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner_value.rb
|
|
539
|
-
- lib/pharmaobservatory/models/orgs_financials200_response.rb
|
|
540
|
-
- lib/pharmaobservatory/models/orgs_financials200_response_rows_inner.rb
|
|
541
|
-
- lib/pharmaobservatory/models/orgs_funding200_response.rb
|
|
542
|
-
- lib/pharmaobservatory/models/orgs_funding200_response_context.rb
|
|
543
|
-
- lib/pharmaobservatory/models/orgs_funding200_response_context_summary.rb
|
|
544
|
-
- lib/pharmaobservatory/models/orgs_funding200_response_rows_inner.rb
|
|
545
|
-
- lib/pharmaobservatory/models/orgs_get200_response.rb
|
|
546
|
-
- lib/pharmaobservatory/models/orgs_get200_response_identity.rb
|
|
547
|
-
- lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner.rb
|
|
548
|
-
- lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner_value.rb
|
|
549
|
-
- lib/pharmaobservatory/models/orgs_get200_response_sections_inner.rb
|
|
550
|
-
- lib/pharmaobservatory/models/orgs_group_sections200_response.rb
|
|
551
|
-
- lib/pharmaobservatory/models/orgs_group_sections200_response_context.rb
|
|
552
|
-
- lib/pharmaobservatory/models/orgs_group_sections200_response_rows_inner.rb
|
|
553
|
-
- lib/pharmaobservatory/models/orgs_group_structure200_response.rb
|
|
554
|
-
- lib/pharmaobservatory/models/orgs_group_structure200_response_context.rb
|
|
555
|
-
- lib/pharmaobservatory/models/orgs_group_structure200_response_rows_inner.rb
|
|
556
|
-
- lib/pharmaobservatory/models/orgs_gxp_sites200_response.rb
|
|
557
|
-
- lib/pharmaobservatory/models/orgs_gxp_sites200_response_context.rb
|
|
558
|
-
- lib/pharmaobservatory/models/orgs_gxp_sites200_response_context_group_companies_inner.rb
|
|
559
|
-
- lib/pharmaobservatory/models/orgs_gxp_sites200_response_rows_inner.rb
|
|
560
|
-
- lib/pharmaobservatory/models/orgs_gxp_sites_map200_response.rb
|
|
561
|
-
- lib/pharmaobservatory/models/orgs_identity200_response.rb
|
|
562
|
-
- lib/pharmaobservatory/models/orgs_import_refusals200_response.rb
|
|
563
|
-
- lib/pharmaobservatory/models/orgs_institutional13f200_response.rb
|
|
564
|
-
- lib/pharmaobservatory/models/orgs_institutional13f200_response_context.rb
|
|
565
|
-
- lib/pharmaobservatory/models/orgs_institutional13f200_response_rows_inner.rb
|
|
566
|
-
- lib/pharmaobservatory/models/orgs_journals200_response.rb
|
|
567
|
-
- lib/pharmaobservatory/models/orgs_list200_response.rb
|
|
568
|
-
- lib/pharmaobservatory/models/orgs_list200_response_pagination.rb
|
|
569
|
-
- lib/pharmaobservatory/models/orgs_list200_response_query.rb
|
|
570
|
-
- lib/pharmaobservatory/models/orgs_list200_response_rows_inner.rb
|
|
571
|
-
- lib/pharmaobservatory/models/orgs_member_children200_response.rb
|
|
572
|
-
- lib/pharmaobservatory/models/orgs_member_identity200_response.rb
|
|
573
|
-
- lib/pharmaobservatory/models/orgs_member_identity200_response_context.rb
|
|
574
|
-
- lib/pharmaobservatory/models/orgs_member_identity200_response_context_identifiers_inner.rb
|
|
575
|
-
- lib/pharmaobservatory/models/orgs_member_identity200_response_context_parent.rb
|
|
576
|
-
- lib/pharmaobservatory/models/orgs_member_identity200_response_rows_inner.rb
|
|
577
|
-
- lib/pharmaobservatory/models/orgs_member_records200_response.rb
|
|
578
|
-
- lib/pharmaobservatory/models/orgs_member_records200_response_context.rb
|
|
579
|
-
- lib/pharmaobservatory/models/orgs_member_records200_response_rows_inner.rb
|
|
580
|
-
- lib/pharmaobservatory/models/orgs_members200_response.rb
|
|
581
|
-
- lib/pharmaobservatory/models/orgs_members200_response_rows_inner.rb
|
|
582
|
-
- lib/pharmaobservatory/models/orgs_org_assets200_response.rb
|
|
583
|
-
- lib/pharmaobservatory/models/orgs_org_assets200_response_rows_inner.rb
|
|
584
|
-
- lib/pharmaobservatory/models/orgs_org_customer200_response.rb
|
|
585
|
-
- lib/pharmaobservatory/models/orgs_org_customer200_response_rows_inner.rb
|
|
586
|
-
- lib/pharmaobservatory/models/orgs_org_gleif200_response.rb
|
|
587
|
-
- lib/pharmaobservatory/models/orgs_org_gleif200_response_rows_inner.rb
|
|
588
|
-
- lib/pharmaobservatory/models/orgs_org_hosted200_response.rb
|
|
589
|
-
- lib/pharmaobservatory/models/orgs_org_hosted200_response_rows_inner.rb
|
|
590
|
-
- lib/pharmaobservatory/models/orgs_org_owned_drugs200_response.rb
|
|
591
|
-
- lib/pharmaobservatory/models/orgs_org_owned_drugs200_response_rows_inner.rb
|
|
592
|
-
- lib/pharmaobservatory/models/orgs_org_ownership200_response.rb
|
|
593
|
-
- lib/pharmaobservatory/models/orgs_org_ownership200_response_context.rb
|
|
594
|
-
- lib/pharmaobservatory/models/orgs_org_ownership200_response_context_truncated.rb
|
|
595
|
-
- lib/pharmaobservatory/models/orgs_org_patent_mentions200_response.rb
|
|
596
|
-
- lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_attribution_inner.rb
|
|
597
|
-
- lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_rows_inner.rb
|
|
598
|
-
- lib/pharmaobservatory/models/orgs_org_people200_response.rb
|
|
599
|
-
- lib/pharmaobservatory/models/orgs_org_people200_response_context.rb
|
|
600
|
-
- lib/pharmaobservatory/models/orgs_org_people200_response_rows_inner.rb
|
|
601
|
-
- lib/pharmaobservatory/models/orgs_org_pipeline200_response.rb
|
|
602
|
-
- lib/pharmaobservatory/models/orgs_org_pipeline200_response_context.rb
|
|
603
|
-
- lib/pharmaobservatory/models/orgs_org_pipeline200_response_context_counts.rb
|
|
604
|
-
- lib/pharmaobservatory/models/orgs_org_pipeline200_response_rows_inner.rb
|
|
605
|
-
- lib/pharmaobservatory/models/orgs_org_programs200_response.rb
|
|
606
|
-
- lib/pharmaobservatory/models/orgs_org_programs200_response_context.rb
|
|
607
|
-
- lib/pharmaobservatory/models/orgs_org_programs200_response_rows_inner.rb
|
|
608
|
-
- lib/pharmaobservatory/models/orgs_org_publications200_response.rb
|
|
609
|
-
- lib/pharmaobservatory/models/orgs_org_publications200_response_rows_inner.rb
|
|
610
|
-
- lib/pharmaobservatory/models/orgs_org_recruitment200_response.rb
|
|
611
|
-
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context.rb
|
|
612
|
-
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_predicted.rb
|
|
613
|
-
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_realized.rb
|
|
614
|
-
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_statuses.rb
|
|
615
|
-
- lib/pharmaobservatory/models/orgs_org_relationships200_response.rb
|
|
616
|
-
- lib/pharmaobservatory/models/orgs_org_relationships200_response_query.rb
|
|
617
|
-
- lib/pharmaobservatory/models/orgs_org_supplier200_response.rb
|
|
618
|
-
- lib/pharmaobservatory/models/orgs_org_supplier200_response_rows_inner.rb
|
|
619
|
-
- lib/pharmaobservatory/models/orgs_org_targets200_response.rb
|
|
620
|
-
- lib/pharmaobservatory/models/orgs_org_targets200_response_rows_inner.rb
|
|
621
|
-
- lib/pharmaobservatory/models/orgs_org_type_tally200_response.rb
|
|
622
|
-
- lib/pharmaobservatory/models/orgs_org_type_tally200_response_context.rb
|
|
623
|
-
- lib/pharmaobservatory/models/orgs_org_type_tally200_response_rows_inner.rb
|
|
624
|
-
- lib/pharmaobservatory/models/orgs_org_us_patents200_response.rb
|
|
625
|
-
- lib/pharmaobservatory/models/orgs_org_us_patents200_response_context.rb
|
|
626
|
-
- lib/pharmaobservatory/models/orgs_org_us_patents200_response_rows_inner.rb
|
|
627
|
-
- lib/pharmaobservatory/models/orgs_overview_digest200_response.rb
|
|
628
|
-
- lib/pharmaobservatory/models/orgs_overview_digest200_response_rows_inner.rb
|
|
629
|
-
- lib/pharmaobservatory/models/orgs_ownership_coverage200_response.rb
|
|
630
|
-
- lib/pharmaobservatory/models/orgs_ownership_coverage200_response_rows_inner.rb
|
|
631
|
-
- lib/pharmaobservatory/models/orgs_ownership_history200_response.rb
|
|
632
|
-
- lib/pharmaobservatory/models/orgs_ownership_history200_response_context.rb
|
|
633
|
-
- lib/pharmaobservatory/models/orgs_ownership_history200_response_rows_inner.rb
|
|
634
|
-
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response.rb
|
|
635
|
-
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context.rb
|
|
636
|
-
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_insider.rb
|
|
637
|
-
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_institutional.rb
|
|
638
|
-
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_shares_outstanding.rb
|
|
639
|
-
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner.rb
|
|
640
|
-
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner_as_of.rb
|
|
641
|
-
- lib/pharmaobservatory/models/orgs_patent_cliff200_response.rb
|
|
642
|
-
- lib/pharmaobservatory/models/orgs_patent_cliff200_response_context.rb
|
|
643
|
-
- lib/pharmaobservatory/models/orgs_patent_cliff200_response_rows_inner.rb
|
|
644
|
-
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response.rb
|
|
645
|
-
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context.rb
|
|
646
|
-
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context_portfolio.rb
|
|
647
|
-
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_rows_inner.rb
|
|
648
|
-
- lib/pharmaobservatory/models/orgs_patents200_response.rb
|
|
649
|
-
- lib/pharmaobservatory/models/orgs_patents200_response_context.rb
|
|
650
|
-
- lib/pharmaobservatory/models/orgs_patents200_response_rows_inner.rb
|
|
651
|
-
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response.rb
|
|
652
|
-
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context.rb
|
|
653
|
-
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context_status_counts.rb
|
|
654
|
-
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_rows_inner.rb
|
|
655
|
-
- lib/pharmaobservatory/models/orgs_peers200_response.rb
|
|
656
|
-
- lib/pharmaobservatory/models/orgs_peers200_response_rows_inner.rb
|
|
657
|
-
- lib/pharmaobservatory/models/orgs_phase_status200_response.rb
|
|
658
|
-
- lib/pharmaobservatory/models/orgs_phase_status200_response_context.rb
|
|
659
|
-
- lib/pharmaobservatory/models/orgs_phase_status200_response_rows_inner.rb
|
|
660
|
-
- lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response.rb
|
|
661
|
-
- lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context.rb
|
|
662
|
-
- lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context_coverage.rb
|
|
663
|
-
- lib/pharmaobservatory/models/orgs_rare_activity200_response.rb
|
|
664
|
-
- lib/pharmaobservatory/models/orgs_rare_activity200_response_context.rb
|
|
665
|
-
- lib/pharmaobservatory/models/orgs_rare_activity200_response_rows_inner.rb
|
|
666
|
-
- lib/pharmaobservatory/models/orgs_registry_shell200_response.rb
|
|
667
|
-
- lib/pharmaobservatory/models/orgs_registry_shell200_response_rows_inner.rb
|
|
668
|
-
- lib/pharmaobservatory/models/orgs_related_conditions200_response.rb
|
|
669
|
-
- lib/pharmaobservatory/models/orgs_related_conditions200_response_rows_inner.rb
|
|
670
|
-
- lib/pharmaobservatory/models/orgs_related_unfolded200_response.rb
|
|
671
|
-
- lib/pharmaobservatory/models/orgs_related_unfolded200_response_rows_inner.rb
|
|
672
|
-
- lib/pharmaobservatory/models/orgs_revenue_by_drug200_response.rb
|
|
673
|
-
- lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_context.rb
|
|
674
|
-
- lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_rows_inner.rb
|
|
675
|
-
- lib/pharmaobservatory/models/orgs_revenue_geography200_response.rb
|
|
676
|
-
- lib/pharmaobservatory/models/orgs_revenue_geography200_response_context.rb
|
|
677
|
-
- lib/pharmaobservatory/models/orgs_revenue_geography200_response_rows_inner.rb
|
|
678
|
-
- lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response.rb
|
|
679
|
-
- lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response_rows_inner.rb
|
|
680
|
-
- lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response.rb
|
|
681
|
-
- lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response_rows_inner.rb
|
|
682
|
-
- lib/pharmaobservatory/models/orgs_scientist_com200_response.rb
|
|
683
|
-
- lib/pharmaobservatory/models/orgs_scientist_com200_response_context.rb
|
|
684
|
-
- lib/pharmaobservatory/models/orgs_scientist_com200_response_rows_inner.rb
|
|
685
|
-
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response.rb
|
|
686
|
-
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner.rb
|
|
687
|
-
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value.rb
|
|
688
|
-
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value_one_of.rb
|
|
689
|
-
- lib/pharmaobservatory/models/orgs_sec_pdufa200_response.rb
|
|
690
|
-
- lib/pharmaobservatory/models/orgs_sec_pdufa200_response_rows_inner.rb
|
|
691
|
-
- lib/pharmaobservatory/models/orgs_supplier_links200_response.rb
|
|
692
|
-
- lib/pharmaobservatory/models/orgs_timeline200_response.rb
|
|
693
|
-
- lib/pharmaobservatory/models/orgs_timeline200_response_rows_inner.rb
|
|
694
|
-
- lib/pharmaobservatory/models/orgs_top_conditions200_response.rb
|
|
695
|
-
- lib/pharmaobservatory/models/orgs_top_conditions200_response_rows_inner.rb
|
|
696
|
-
- lib/pharmaobservatory/models/orgs_top_drugs200_response.rb
|
|
697
|
-
- lib/pharmaobservatory/models/orgs_top_drugs200_response_rows_inner.rb
|
|
698
|
-
- lib/pharmaobservatory/models/orgs_trials_per_year200_response.rb
|
|
699
|
-
- lib/pharmaobservatory/models/orgs_unmatched_revenue200_response.rb
|
|
700
|
-
- lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner.rb
|
|
701
|
-
- lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner_value.rb
|
|
191
|
+
- lib/pharmaobservatory/models/biomarker_bqp_assertions_response.rb
|
|
192
|
+
- lib/pharmaobservatory/models/biomarker_bqp_assertions_row.rb
|
|
193
|
+
- lib/pharmaobservatory/models/biomarker_cdx_assertions_response.rb
|
|
194
|
+
- lib/pharmaobservatory/models/biomarker_cdx_assertions_response_build.rb
|
|
195
|
+
- lib/pharmaobservatory/models/biomarker_cdx_assertions_response_freshness.rb
|
|
196
|
+
- lib/pharmaobservatory/models/biomarker_cdx_assertions_response_scope.rb
|
|
197
|
+
- lib/pharmaobservatory/models/biomarker_cdx_assertions_row.rb
|
|
198
|
+
- lib/pharmaobservatory/models/biomarker_evidence_response.rb
|
|
199
|
+
- lib/pharmaobservatory/models/biomarker_evidence_row.rb
|
|
200
|
+
- lib/pharmaobservatory/models/biomarker_literature_response.rb
|
|
201
|
+
- lib/pharmaobservatory/models/biomarker_literature_row.rb
|
|
202
|
+
- lib/pharmaobservatory/models/biomarker_publishing_companies_response.rb
|
|
203
|
+
- lib/pharmaobservatory/models/biomarker_publishing_companies_row.rb
|
|
204
|
+
- lib/pharmaobservatory/models/biomarker_variant_mentions_response.rb
|
|
205
|
+
- lib/pharmaobservatory/models/biomarker_variant_mentions_row.rb
|
|
206
|
+
- lib/pharmaobservatory/models/biomarkers_record.rb
|
|
207
|
+
- lib/pharmaobservatory/models/biomarkers_response.rb
|
|
208
|
+
- lib/pharmaobservatory/models/biomarkers_row.rb
|
|
209
|
+
- lib/pharmaobservatory/models/cell_lines_record.rb
|
|
210
|
+
- lib/pharmaobservatory/models/cell_lines_response.rb
|
|
211
|
+
- lib/pharmaobservatory/models/cell_lines_row.rb
|
|
212
|
+
- lib/pharmaobservatory/models/companies_record.rb
|
|
213
|
+
- lib/pharmaobservatory/models/companies_response.rb
|
|
214
|
+
- lib/pharmaobservatory/models/companies_row.rb
|
|
215
|
+
- lib/pharmaobservatory/models/company_members_response.rb
|
|
216
|
+
- lib/pharmaobservatory/models/company_members_row.rb
|
|
217
|
+
- lib/pharmaobservatory/models/company_programs_response.rb
|
|
218
|
+
- lib/pharmaobservatory/models/company_programs_row.rb
|
|
219
|
+
- lib/pharmaobservatory/models/company_targets_response.rb
|
|
220
|
+
- lib/pharmaobservatory/models/company_targets_row.rb
|
|
221
|
+
- lib/pharmaobservatory/models/dataset_attribution.rb
|
|
222
|
+
- lib/pharmaobservatory/models/dataset_build_state.rb
|
|
223
|
+
- lib/pharmaobservatory/models/dataset_column.rb
|
|
224
|
+
- lib/pharmaobservatory/models/dataset_listing.rb
|
|
225
|
+
- lib/pharmaobservatory/models/dataset_summary_list.rb
|
|
226
|
+
- lib/pharmaobservatory/models/dataset_summary_list_datasets_inner.rb
|
|
227
|
+
- lib/pharmaobservatory/models/drug_patent_cliff_response.rb
|
|
228
|
+
- lib/pharmaobservatory/models/drug_patent_cliff_row.rb
|
|
229
|
+
- lib/pharmaobservatory/models/institutional_holdings_response.rb
|
|
230
|
+
- lib/pharmaobservatory/models/institutional_holdings_row.rb
|
|
231
|
+
- lib/pharmaobservatory/models/legal_entities_record.rb
|
|
232
|
+
- lib/pharmaobservatory/models/legal_entities_record_attributes.rb
|
|
233
|
+
- lib/pharmaobservatory/models/legal_entities_response.rb
|
|
234
|
+
- lib/pharmaobservatory/models/legal_entities_row.rb
|
|
235
|
+
- lib/pharmaobservatory/models/pdufa_dates_response.rb
|
|
236
|
+
- lib/pharmaobservatory/models/pdufa_dates_row.rb
|
|
237
|
+
- lib/pharmaobservatory/models/query_error.rb
|
|
238
|
+
- lib/pharmaobservatory/models/query_response.rb
|
|
239
|
+
- lib/pharmaobservatory/models/query_response_columns_inner.rb
|
|
240
|
+
- lib/pharmaobservatory/models/query_run_request.rb
|
|
241
|
+
- lib/pharmaobservatory/models/result_page.rb
|
|
242
|
+
- lib/pharmaobservatory/models/site_beds_yearly_response.rb
|
|
243
|
+
- lib/pharmaobservatory/models/site_beds_yearly_row.rb
|
|
244
|
+
- lib/pharmaobservatory/models/site_cro_trials_response.rb
|
|
245
|
+
- lib/pharmaobservatory/models/site_cro_trials_row.rb
|
|
246
|
+
- lib/pharmaobservatory/models/site_hospitals_response.rb
|
|
247
|
+
- lib/pharmaobservatory/models/site_hospitals_row.rb
|
|
248
|
+
- lib/pharmaobservatory/models/site_investigators_response.rb
|
|
249
|
+
- lib/pharmaobservatory/models/site_investigators_row.rb
|
|
250
|
+
- lib/pharmaobservatory/models/site_trial_conditions_response.rb
|
|
251
|
+
- lib/pharmaobservatory/models/site_trial_conditions_row.rb
|
|
252
|
+
- lib/pharmaobservatory/models/site_trial_drugs_response.rb
|
|
253
|
+
- lib/pharmaobservatory/models/site_trial_drugs_row.rb
|
|
254
|
+
- lib/pharmaobservatory/models/site_trials_response.rb
|
|
255
|
+
- lib/pharmaobservatory/models/site_trials_row.rb
|
|
256
|
+
- lib/pharmaobservatory/models/sites_record.rb
|
|
257
|
+
- lib/pharmaobservatory/models/sites_record_attributes.rb
|
|
258
|
+
- lib/pharmaobservatory/models/sites_response.rb
|
|
259
|
+
- lib/pharmaobservatory/models/sites_row.rb
|
|
260
|
+
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_response.rb
|
|
261
|
+
- lib/pharmaobservatory/models/sponsor_recruitment_by_phase_row.rb
|
|
262
|
+
- lib/pharmaobservatory/models/sponsor_recruitment_duration_response.rb
|
|
263
|
+
- lib/pharmaobservatory/models/sponsor_recruitment_duration_row.rb
|
|
264
|
+
- lib/pharmaobservatory/models/sponsor_trial_start_forecast_response.rb
|
|
265
|
+
- lib/pharmaobservatory/models/sponsor_trial_start_forecast_row.rb
|
|
266
|
+
- lib/pharmaobservatory/models/sponsor_trials_response.rb
|
|
267
|
+
- lib/pharmaobservatory/models/sponsor_trials_row.rb
|
|
702
268
|
- lib/pharmaobservatory/version.rb
|
|
703
269
|
homepage: https://pharmaobservatory.com
|
|
704
270
|
licenses:
|